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 ABSTRACT          
 Parallel plate flow chambers, simulating in vivo fluid shear stress, provide a real 
time insight into the dynamic process of platelet aggregation and investigation of 
endothelial cell response to shear stress. This thesis describes the design and validation of 
– 1) A simple parallel plate flow chamber to study effects of shear stress on endothelial 
cells. This flow chamber is easy to use, inexpensive and fast to manufacture as compared 
to the flow devices reported previously. Moreover, it minimizes the number of cells and 
solution volumes to be used. It can be used as an effective in vitro system to study the 
effects of fluid shear stress on the structure and function of endothelial cells.  2)  A four 
channel cylindrical flow device, constructed out of polydimethylsiloxane (PDMS) on 
microscope coverslips, to study platelet aggregation under in vivo like conditions. The 
novel aspect of this flow device is the surface chemistry we have devised for the facile 
patterning of immobilized proteins (fibrinogen and collagen) onto polydimethylsiloxane 
surfaces. The flow method introduced here was employed to determine the effect of 
thymosin β 4, a G-actin sequestering peptide, on the deposition of ADP-activated platelets 
onto fibrinogen cross-linked flow chambers. Platelets carry and release large amounts of 
thymosin β 4. Yet the role of thymosin β 4 on platelet thrombus formation has not been 
fully investigated. We demonstrate that thymosin β 4 has a dual role in platelet 
aggregation. Our results show that at low doses thymosin β 4 promotes platelet deposition 
and aggregation by yet unknown mechanism. However, platelet adhesion to fibrinogen is 
inhibited at high concentrations of thymosin β 4.      
 Exogenous thymosin β 4 has also been reported to promote wound healing, 
inflammation reduction and protection of human cornea epithelial cells against oxidative 
damage. Herein, we show that thymosin β 4 can also assuage endoplasmic reticulum 
stress in retinal pigment epithelium cells (RPE). Thymosin β 4 pre treatment before 
introducing endoplasmic reticulum stress decreases ROS, cholesterol levels and nuclear 
translocation of NFκB in RPE.         
 In conclusion, this body of work demonstrates the utility of flow devices to study 
platelet function and effects of shear stress in endothelial cells under in vivo like 
conditions. This work also reveals the role of thymosin β 4 in platelet function and 
alleviating ER stress in RPE, both of which might of considerable therapeutic relevance.  
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1. Platelets 
Hemostasis is a co-ordinated event of various cellular and biochemical interactions, 
which   involves the arrest of bleeding, formation of platelet aggregates and hence wound 
healing. Blood platelets play a very important role in every aspect of hemostasis. Platelets 
are small (2 to 4 µm in diameter), anuclear and disc-shaped and colourless cellular 
structures with a large number of secretory granules. These cells are derived from mature 
megakaryocytes via a process called thrombopoiesis. In the circulation of normal human 
beings, the number of platelets is in the range of 150,000 to 350,000 per µL. Their 
average life span is 6-10 days, after which they are destroyed by phagocytosis in the 
spleen. 
Platelets have an important role in blood coagulation. Upon vascular injury, 
platelets are activated by subendothelial adhesive proteins like collagen and by a wide 
variety of soluble agonists including ADP, thrombaxane A2, thrombin and serotonin. 
These agonists induce signalling pathways by binding to their respective receptors on 
platelets, which leads to various signalling events such as platelet cytoskeletal changes 
and granule secretion. Upon activation by the agonists, platelets change their shape and 
adhere to newly exposed subendothelial tissues. The contents of the secretory granules (α 
granules and dense granules) are released at the site of vascular damage, which play an 
important role in haemostasis and thrombus formation (Zucker et al 1985). Platelet shape 
change and aggregation are of central importance for the formation of platelet thrombi 
and subsequently wound healing. Platelet plug formation at the site of injury occurs in 
three stages.      
a) Platelet adhesion – Platelets detect vascular damage and adhere to the exposed 
subendothelium forming a monolayer of activated platelets. 
b) Platelet release reaction – The platelets release active substances that are stored 
in their secretory granules. Serotonin, ADP, ATP and calcium are released by 
dense granules. Lysosomes release hydrolytic enzymes and α granules release 
platelet factor 4 (PF-4), beta thromboglobulin, platelet- derived growth factor 
(PDGF), fibrinogen, fibronectin, von Willebrand factor and albumin. The agonists 
released by the attached platelets activate and recruit more platelets.  
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c) Platelet aggregation – The recruited platelets aggregate with those already bound 
and form a platelet plug, which serves as a surface for fibrin deposition. The 
platelet plug formed is stabilized, eventually leading to wound healing. 
 
1.1 Platelet receptors and signalling pathways 
Platelet adhesion and aggregation on the exposed extracellular matrix (ECM) requires the 
coordinated interaction of different platelet surface receptors with adhesive 
macromolecules. Platelet receptors play a key role in regulating the cascade of events 
whereby circulating resting platelets make the rapid transition to an adhered, activated 
and aggregated thrombus. The mutation or absence of the receptors or binding proteins 
can affect the ability of the platelets to respond to vascular injury.    
 A wide variety of transmembrane receptors covers the platelet membrane, 
including many integrins (αIIbβ3, α2β1), G-protein coupled seven transmembrane receptors 
(GPCR) (PAR-1 and PAR-4) thrombin receptors, P2Y1 and P2Y12 receptors and proteins 
belonging to the immunoglobulin superfamily (GP VI). Each of these receptors is capable 
of binding one or more ligand. Platelet receptors have a prominent role in the hemostatic 
function of platelets, allowing specific interactions and functional responses of vascular 
adhesive proteins and of soluble platelet agonists. Platelet receptors and their ligands are 
listed in Table 1. 
TABLE 1 – Platelet membrane receptors and their ligands   
Platelet Receptor Ligands 
GP IIb/IIIa, integrin αIIbβ3 Fibrinogen, vWF, Fibronectin 
GP Ib-V-IX vWF 
GP Ia/IIa, α2β1 Collagen 
Protease activatable receptor (PAR) Thrombin 
α- adrenergic sites Epinephrine 
GP IV, GP VI Collagen 
P2Y1 and P2Y12 ADP 
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Figure 1 – Platelet receptors and ligand interactions (Image taken from Rivera et al 
2009). 
 
                    
The platelet membrane receptors bind extracellular factors in response to platelet 
activation by different agonists, resulting in platelet adhesion and aggregation. PAR-1 and 
PAR-4 in the platelet membrane bind thrombin and mediate adhesion. Collagen can bind 
to either GP VI or integrin α2β1. Von Willebrand Factor (vWF), epinephrine and 
thromboxane A2 (TxA2) bind to GP Ib/IX/V, α2A and thromboxane receptor (TP) 
respectively. The binding of these agonists transmits intracellular signals leading to 
elevation of cytosolic Ca
2+
, cytoskeletal changes, secretion of agonists such as ADP (that 
activates G protein-coupled P2Y1 and P2Y12 receptors), and activation of the integrin 
αIIbβ3 that binds vWF or fibrinogen and mediates platelet aggregation  
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a) GP VI – It is a 62kDa platelet–specific type 1 transmembrane glycoprotein of the 
immunoglobin superfamily. It is an important collagen receptor of high potency in terms 
of initiating platelet activation, aggregation and thrombus formation (Nieswandt et al 
2003). It is one of the most important members of immunoglobin (Ig) suprefamily on 
platelets. It binds ligands including collagen, collagen related peptide (CRP) and the 
snake venom protein, convulxin.         
 Fc receptor gamma (FcRγ) is required for GP VI expression and is associated with 
the GP VI via a salt bridge in the transmembrane domains of GP VI (arginine) and FcRγ 
(aspartic acid) (Farndale et al 2004). The signalling pathway involves the FcRγ- chain 
and the Src kinases (likely Fyn/Lyn), the adapter protein; linker of activated T cells 
(LAT), and leads to the activation of phospholipase C gamma 2 (PLCγ2). GP VI initiates 
binding to fibrillar collagen under flow conditions, which then activates integrin α2β1 
which binds collagen more tightly. GP VI deficiencies cause only a mild bleeding 
tendency, probably because integrin α2β1 is able to minimally initiate collagen binding.                                         
 
b) GP Ib-IX-V – GP Ib-IX-V consists of four transmembrane glycoproteins, which are 
all members of the leucine rich protein family (Berndt et al 1995). It is a complex of 
glycoproteins constituting GP Ibα and GP Ibβ linked by a disulfide bond, and non 
covalently linked to GP IX and GP V. This receptor is constitutively expressed on the 
platelet plasma membrane. GPIbα is the major ligand-binding subunit, with a globular N-
terminal ligand-binding domain elevated from the cell surface by a sialomucin core 
(Andrews et al 2003). It also plays a substantial role in platelet interaction with activated 
endothelial cells and with leukocytes, through the binding of P-selectin and Mac-1 
(αMβ2), respectively. There are around 25,000 copies of the GP Ib-IX complex per platelet 
and there are approximately half as many copies of GP V per platelet, which suggests that 
GP V forms a 1:2 complex with GP Ib-IX on the platelet surface (Modderman et al 
1992).            
 Under high shear, GP Ib-IX-V complex interacts with vWF, an extracellular 
multimeric adhesive glycoprotein associated with subendothelial matrix, and mediates the 
initial adhesion of platelets to the subendothelium. vWF undergoes a conformational 
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change when it is bound to matrix or under high shear conditions, which permits its 
binding to  GP Ib-IX-V complex.  
 
 
Figure 2 – Platelet signalling through GP VI and GP Ib/IX/V (Image taken from 
Rivera et al 2009).                    
 
GP VI has a short cytoplasmic tail which binds Fyn and Lyn Src kinases. FcRγ complexes 
with GP VI, has an immunoreceptor tyrosine based activation motif (ITAM) which acts 
as the signal transducing subunit of the receptor. Collagen binding to the GP VI 
phosphorylates ITAM by Src kinases which activate Syk and downstream signalling 
pathways. These downstream pathways consist of formation of a signalosome, composed 
of various adapter and effector proteins (LAT, SLP-76, Gads), and ultimately activates 
PLCγ2. PLC catalyzes the hydrolysis of phosphatidyl inositol 4, 5 bisphosphate (PIP2), 
thus leading to release of inositol 1, 4, 5 triphosphate (IP3) and diacylglycerol (DAG) and 
hence integrin activation. The cytoplasmic tail of GP Ibα is associated with filamin and 
calmodulin, which links it to the relevant signalling proteins including Src related 
tyrosine kinase, focal adhesion kinase (FAK), GTPase activating protein and PI3K. When 
vWF binds GP 1b/IX/V, activation signals such as cytoplasmic Ca
2+
 release, ADP release 
and αIIbβ3 activation are elicited. The actual mechanisms as to how these signals are 
transmitted are not yet clear.        
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c) Integrins – Integrins are a ubiquitously expressed family of transmembrane receptors 
which consist of an α and β subunit. Integrins are present on platelet membrane in a low 
affinity state until platelets are activated by agonists. Platelet activation transforms 
integrins into a high affinity form and they can bind their ligands. Integrin αIIbβ3 receptor 
is a dominant receptor, which is present in large copy numbers (40,000 – 80,000 per 
platelet) on the platelet surface. It acts as a principle receptor which mediates platelet 
aggregation through binding of plasma fibrinogen (Gruner et al 2003). Its absence or 
deficiency causes the most common bleeding disorder Glanzmann thrombasthenia. 
 The second most important integrin receptor on platelet surface is α2β1. It is the 
major collagen adhesion receptor and is present at about 2000 – 4000 copies per platelet. 
The α2β1 integrin, commonly referred to as GP Ia/IIa, also plays a role in the adhesion of 
platelets to collagen and subsequent optimal activation (Sarratt et al 2005).  
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Figure 3 – Integrin activation (Image taken from Nieswandt et al 2009).   
 
Phospholipase C (PLC) is activated after stimulation by the agonists. PLC catalyzes the 
hydrolysis of phosphatidyl inositol 4,5 bisphosphate (PIP2) into inositol 1,4,5 triphosphate 
(IP3) and diacylglycerol (DAG). IP3 binds and activates IP3 receptors on the endoplasmic 
reticulum (ER) membrane resulting in the release of calcium from the ER. Ca
2+
 
concentration inside the cell is further increased by the opening of plasma membrane Ca
2+
 
channel Orail by stromal interaction molecule 1 (STIM1). DAG and Ca
2+
 activate protein 
kinase C (PKC) and diacylglycerol-regulated guanine nucleotide exchange factor I 
(CalDAG-GEFI), which further activates and translocates Rap1 to the plasma membrane. 
RAP1 effector molecule RIAM interacts with Rap1-GTP and talin-1. This interaction 
exposes the integrin binding site of talin-1. The salt bridge between the transmembrane 
regions of α and β integrin subunits is disrupted by the binding of talin-1, which results in 
a conformational change in the extracellular domains and hence ligand binding. This step 
also requires binding of kindlin-3 to the NPXY motif of the integrin β tail.  
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 d) ADP receptors – ADP plays a central role in regulating platelet function. It induces 
platelet aggregation via the activation of 2 major ADP receptors, P2Y1 and P2Y12. ADP 
binds the Gq-protein-linked P2Y1 receptor on platelets, which causes a change in cell 
shape, mobilization of calcium, and initiation of reversible aggregation. It also binds the 
Gi-linked P2Y12 receptor to amplify aggregation via adenylyl-cyclase-mediated cyclic 
AMP production (Communi et al 2000). This receptor is also a main target for many anti-
thrombotic drugs. Coactivation of Gq-coupled P2Y1 and Gi-coupled P2Y12 receptors is 
essential for ADP-induced platelet aggregation (Jin et al 1998).    
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 Figure 4 – ADP receptors and downstream signalling (Image taken from Kim et al 
2011). 
             
 
ADP activates platelets through Gq coupled P2Y1 receptor and Gi-coupled P2Y12 receptor 
and causes a number of downstream intracellular signalling events that contribute to 
fibrinogen receptor activation and platelet aggregation. G protein gated inwardly 
rectifying potassium channels, PI3K, Akt, ERK, Rap 1b and Src family kinases are all 
activated through the P2Y12 receptor. Both Rap1b and Akt are signalling mediators that 
contribute to platelet aggregation and are activated in a PI3K-dependent manner. RhoA 
protein is activated by P2Y1, which causes cytoskeletal and shape changes in activated 
platelets. These receptors are also the target of many anti-thrombotic drugs including 
clopidogrel, prasugrel and elinogrel. MRS2179 is P2Y1 antagonist.  
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1.2 Major proteins involved in thrombosis                            
Blood coagulation cascade involves numerous different proteins eg fibrinogen, collagen, 
tissue factor, factor VII, factor VIII, vWF etc. The properties and functions of 3 major 
proteins related to the work in this thesis are described below. 
a) Fibrinogen – Fibrinogen is a large (340 kDa), complex glycoprotein which is 
primarily synthesized by hepatocytes. It consists of three pairs of polypeptide chains, Aα, 
Bβ and γ, linked by 29 disulfide bonds. These polypeptide chains are encoded by different 
genes located on chromosome 4. It is normally present in blood plasma at a concentration 
of about 2.5g/L with a half life of around 100 h. The primary platelet receptor for 
fibrinogen binding is integrin αIIbβ3 (Weisel 2005). Fibrinogen is essential for hemostasis 
and plays an important role in wound healing, inflammation and other biological 
functions.         
 Fibrinogen is not only necessary for platelet aggregation, which is an initial step in 
hemostasis but also in the formation of insoluble fibrin clots in the final stages of the 
blood coagulation cascade. Fibrinogen binds to integrin receptor αIIbβ3 on the activated 
platelets and act as a bridge to link platelets causing platelet aggregation and hence 
thrombus formation. Human fibrinogen contains three integrin binding sites: two 
arginine-glycine-aspartic acid (RGD) sequences within the Aα chain and a non RGD 
sequence in the γ chain (Weisel 2005).      
 Fibrinogen also plays a role during inflammation and immune response and 
mediates the adhesion and transendothelial migration of leukocytes. The synthesis of 
fibrinogen is increased during inflammation. Two leukocyte integrins, αMβ2 
(CD11b/CD18, Mac-1) and αXβ2 (CD11c/CD18) are the main fibrinogen receptors 
expressed on neutrophils, monocytes, and macrophages. Fibrinogen interacts with 
CD11b/CD18 and intercellular adhesion molecule-1 (ICAM-1) on endothelial cells and 
acts as a bridging molecule to enhance leukocyte adhesion to endothelial cells (Languino 
et al 1993; Simmons et al 1988).                             
 
b) Collagen – Collagen is the most abundant protein in the human body and a major 
protein of the extracellular matrix. Collagen plays a major role in the hemostatic cascade. 
Platelet adhesion and aggregation on collagen is an integrated process that involves 
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various platelet receptors, including GP VI and integrin α2β1. The human genome has 
genes for more than 20 forms of collagen. Approximately 9 forms of collagen are 
expressed in the vascular wall (Type I, III, IV, V, VI, VIII, XII, XIV), of which types I 
and III are the major constituents of the extracellular matrix. Repetitive Gly–X–Y 
sequences are the characteristic feature of the primary structure of triple-helical regions of 
collagen. Gly– Pro–Hyp (GPO) is the most prevalent sequence, which forms about 10% 
of the primary structure of collagen types I and III (Baum et al 1999). For the close 
packing of the chains, every third residue must be glycine.      
 GP Ia/IIa (α2β1) and GPVI are the two major collagen binding receptors present on 
platelet membrane. Under normal conditions, collagen is not exposed to flowing blood. 
After vascular injury, collagen becomes exposed to the flowing blood; the platelets 
adhere to the matrix and form an aggregate. Under high shear rates, platelet adhesion to 
collagen requires vWF (Sixma et al 1997). 
 
c) von Willebrand Factor (vWF) – vWF is a multimeric adhesive glycoprotein present 
in the plasma, the subendothelial matrix and on the surface of activated endothelial cells. 
vWF is stored in storage granules (Weibel-Palade) of endothelial cells and α granules of 
platelets and is released upon activation of both types of cells.  vWF has binding sites for 
platelet GP Iba and GP IIb-IIIa, and for various subendothelial constituents, including 
collagen types I, III, and VI. For the initial tethering of flowing platelets at the very high 
shear rates found in small arteries and arterioles, the interaction between glycoprotein Ib-
V-IX (GPIb-V-IX) and von vWF immobilized on collagen is very critical (Moroi et al 
1999).                                              
 
1.3 Methods to study platelet function 
1. Light transmission aggregometery 
Aggregometry has been used as a standard approach to study platelet aggregation in 
research. The use of light transmission through platelet suspensions to determine 
aggregation was introduced in the early 1960s (Born et al 1962). Shape change and 
aggregation can be studied with a platelet aggregometer, which records the transmission 
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of light through a stirred platelet suspension. The agonist (ADP, thrombin, collagen) is 
added to the platelet suspension and the dynamic measure of platelet aggregation is 
recorded over time at 600nm. This platelet aggregation test can be done by using platelet 
rich plasma (PRP) maintained at 37
o
 C. When the agonist is added, the platelets aggregate 
and absorb less light and so the transmission increases. The change in optical density can 
be plotted to view the aggregation curve. Lumiaggregometry is a modification of light 
transmission aggregometry which measures platelet secretion along with platelet 
aggregation. 
 
2. Cone and plate viscometers 
Fluid mechanical forces can exert profound effects on blood cell function. Over the past 
years, shear forces generated by blood flow have been recognized to have a significant 
impact on platelet adhesion and thrombus formation. Cone and plate viscometers have 
been used for the continuous measure of platelet agglutination generated by shear forces 
(Fukuyama et al 1989). The role of shear forces in inducing platelet activation has been 
measured by subjecting platelets in suspension to a range of shear rates in a viscometer 
(Goto et al 1998, 2002; Ikeda et al 1991).       
 As shown in Fig. 5, the cone is of a very shallow angle and is in bare contact with 
the plate. The platelet suspension is placed between the cone and plate and rotation of the 
cone at a calculated rate induces shear in the suspension. The rate of shear as well as the 
shear patterns can be controlled by the angle of the cone (α), the speed of rotation (ω), the 
viscosity of the medium (µ) and the distance between the cone (h(r)) and the plate. The 
platelets can be exposed to different range of shear stress and the sample volume required 
is around 500µL – 2mL.        
 A major advantage of a cone and plate viscometer is the constant shear rate 
throughout the entire sample. It requires very low volumes of blood/platelet suspensions 
and can be used to study both laminar and turbulent flows. It allows measurement of 
relatively high shear rates, requires small sample volumes and is easy to clean. The main 
disadvantage of the cone and plate viscometer is that it has geometric disparity from the 
vessels in the cardiovascular system. Also, it cannot be used to study platelet function in 
real time.          
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 Figure 5 – Cone and plate viscometer. 
 
3. Perfusion chambers 
Wall shear has been identified as an important parameter governing the growth of platelet 
thrombi. The platelets experience shear stresses in the range of 1 – 60 dyne/cm2 in the 
venous and arterial circulation. The perfusion chambers are used to study the influence of 
laminar blood flow at various shear rates on thrombus formation.    
 A perfusion device consists of a perfusion chamber with a glass coverslip, a 
pump, vials containing blood/platelet samples and tubing to connect the chamber and the 
pump. The matrix proteins (collagen, fibrinogen) are coated on the glass coverslips. The 
main advantage of these perfusion chambers is that they allow studies at various 
pathophysiological shear rates and also, coating the chamber surfaces with matrix 
proteins is a very simple procedure. These perfusion chambers also allow us to study the 
dynamics of platelet aggregation in real time. The limitation of these chambers is that 
blood flow is pulsatile and blood vessels can dilate, whereas in these flow chambers the 
blood flow is constant and walls are rigid.       
 Parallel plate flow chambers are the most commonly used perfusion chambers to 
mimic flow conditions occurring in vivo and study platelet function in vitro. The role of 
various platelet membrane receptors, adhesive proteins at the vessel wall, plasma 
proteins, thrombin formation and shear rate on platelet adhesion and aggregate formation 
can be investigated using these perfusion chambers. Various studies have used these 
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parallel plate flow chambers to determine the interaction of platelets with adhesive 
surfaces (collagen, fibrinogen, vWF) at various shear rates (Savage et al 1996; Loncar et 
al 2006). Tubular flow chambers which retain the cylindrical shape of the vasculature 
have been used to study the growth and stability of platelet aggregates and also to study 
the flow mechanisms for depositing platelets on various surfaces (Badimon et al 1987). 
Flow chambers with built in eccentric cosine shaped stenoses in the blood flow channel 
have been used to study the effects of fluid dynamic factors on thrombus formation at 
arterial stenotic lesions (Barstad et al 1994). Apart from the conventional flow chambers, 
microfluidic devices are also used, which reduce the blood volumes required for platelet 
studies (Gutierrez et al 2008).         
                                   
 
 
 
 
 
 
 
 
16 
 
 
 
Figure 6 – Perfusion Chamber (Image taken from www.dagan.com) 
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2. Shear Stress 
 In normal physiological conditions, various mechanical forces act on blood vessels and 
the endothelial cells lining them. Two types of superficial stresses develop at the vessel 
walls due to blood flow – circumferential stress due to variation of pulse pressure inside 
blood vessels and shear stress due to blood flow. These forces consist of pressure acting 
perpendicular to the vessel wall, cyclic strain, and shear stress acting parallel to the wall, 
creating a frictional shear force on the surface of the endothelium. Shear stress is 
measured in dynes/cm
2
. For Newtonian fluids flowing upon a planar surface, shear stress 
is calculated as          
    τ = μ du/dy                 
where τ is shear stress, μ is kinetic viscosity, u is fluid velocity, y is distance from the 
surface and du/dy is the velocity gradient (Shames et al 2003).    
 The arteries and veins are exposed to different levels of shear stress, which may 
produce alterations in the structure, exposure, or clustering of externally oriented 
molecules in cell membranes. Normal time-average levels of fluid shear stress in the 
venous circulation are approximately 1 – 6 dyne/cm2, and in the arterial circulation 
approximately 5 – 60 dyne/cm2. In contrast, higher shear stress values can be observed in 
arteries with strong curvatures such as aortic arches, arterioles and vasculature partially 
obstructed by atherosclerosis (McDonald et al 1974).     
  
                       
2.1 Role of shear stress in platelet adhesion and aggregation                 
Shear stress has an important role in maintaining vascular homeostasis. Various studies 
have focused on the physiological effects of shear stress. Blood rheology is one of the key 
factors regulating the dynamics of thrombus development. The mechanisms of platelet 
deposition and thrombus growth are to a large extent determined by the alterations in the 
local hemodynamic environment (Mustard et al 1966). In healthy arteries, blood flow is 
laminar and platelets are exposed to uniform hemodynamic forces during hemostatic plug 
formation. At the site of vascular injury, shear forces generated by the flowing blood play 
an important role in platelet adhesion mechanisms. These mechanical forces not only 
transport platelets to the vessel wall but also dictate the role of various receptors in 
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mediating platelet adhesion. Activation of platelets by pathologically high shear stress can 
lead to arterial thrombotic disease.       
 High fluid shear may trigger platelet aggregation (Kroll et al 1996; Andrews et al 
1997). This condition is known as shear induced platelet aggregation (SIPA) and is 
known to play an important role in the pathogenesis of various diseases including 
atherosclerosis and acute myocardial infarction. Rapid and dramatic changes in blood 
flow may activate passing blood platelets. Various studies on effects of shear rates have 
shown that increasing shear stress leads to increased deposition of platelets onto 
thrombogenic surfaces and increased rates of thrombus growth (Turitto et al 1979; Ikeda 
et al 1991; Tsuji et al 1999; Ruggeri et al 2006). A recent study has demonstrated that at 
pathological shear rates (> 10,000s
-1
), large rolling aggregates can develop independently 
of integrin αIIbβ3 and platelet activation (Ruggeri et al 2006).    
 Platelet aggregation is a consequence of the bridging of platelet surface integrin 
αIIbβ3, by fibrinogen. Although the receptor complexes in resting or unactivated platelets 
do not bind the bridging ligand, high shear forces are thought to induce conformational 
changes in the GpIb/IX/V complex or vWF, and consequent platelet aggregation via the 
bridging molecule vWF (Ikeda et al 1991; Kroll et al 1996). vWF binding to αIIbβ3is 
minimal, but when high shear stresses are applied to platelets, vWF binds to αIIbβ3 as well 
as to the GP Ib/IX/V complex, and this binding contributes substantially to direct shear-
induced platelet aggregate formation (Goto et al 1995).     
 In small arteries and arterioles where shear rate is very high, initial platelet 
adhesion depends on the binding of GP Ibα to immobilized vWF. This interaction is 
crucial for the initial tethering of flowing platelets. This complex continues to recruit 
platelets, thereby increasing the shear rate due to growing thrombi, however this binding 
is not sufficient to make stable platelet aggregates and the platelets continue to be 
translocated in the direction of blood flow. It can keep platelets in contact with the surface 
and with each other only for a short time. High shear stress induces binding of platelet 
GP-IX-V to plasma von Willebrand factor (vWF) which initiates platelet aggregation 
(Savage et al 1998). This molecular mechanism initiates various signalling pathways 
which lead to increased intracellular calcium and αIIbβ3 integin receptor activation. This 
leads to thrombus formation which can block blood supply to the heart and brain causing 
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heart attack and stroke (Kroll et al 1996; Gawaz et al 2004). Activated platelets also 
interact with leukocytes circulating in the blood flow and mediate platelet-leukocyte-
endothelial cell adhesion. In atherothrombosis, platelets promote the interaction of 
inflammatory leukocytes with the vessel wall, which initiates formation of atherosclerotic 
plaques (Gawaz et al 2004; Massberg et al 2002). 
 
2.2 Endothelial cell responses to shear stress                     
Endothelial cells constitute the inner lining of blood vessels and constantly experience 
fluid shear stress, the tangential component of hemodynamic stresses. When shear stress 
is applied on the luminal surface of endothelial cells, the mechanical-chemical signaling 
can be transmitted throughout the cell and to cell– extracellular matrix (ECM) adhesions 
on the luminal surface of endothelial cells. Endothelial cell surfaces are equipped with 
various mechanoreceptors which convert physical stresses into biochemical signals. 
Endothelial cells sense shear stress and respond by modifying gene expression, 
intracellular signalling, protein expression and other cell functions. Under normal 
conditions, the blood flow is unidirectional and laminar, whereas low and disturbed blood 
flow promotes development of atherosclerotic plaques (Davies et al 1995).  
 Numerous studies have been done in vitro and in vivo to demonstrate the effects of 
shear stress on the morphology and cellular behaviour of endothelial cells. Sustained 
shear stress results in reorientation of the actin cytoskeleton, microtubules, and 
intermediate filaments in the direction of flow (Malek et al 1996; Girard et al 1995). 
Some of the early responses of endothelial cells to shear stress such as the activation of 
Ca
2+
 and K
+
 transmembrane channels (Yoshikawa et al 1997) and platelet endothelial cell 
adhesion molecule 1 (PECAM-1) phosphorylation (Osawa et al 1997) can be detected 
within a few seconds after the onset of flow. Shear stress also leads to the activation and 
phosphorylation of various signalling molecules e.g. MAP kinases (Tseng et al 1995), 
focal adhesion kinase, jun C terminal kinase (Li et al 1997) and protein kinase C (Traub 
et al 1997). Laminar shear stress also enhances endothelial cell migration in wound 
healing (Li et al 2002; Hsu et al 2001; Albuquerque et al 2000). Physiological shear 
stress decreases the rate of apoptosis from growth factor depletion, tumor necrosis factor 
α or hydrogen peroxide exposure (Levesque et al 1990; Chiu et al 1998) via activation of 
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Akt and attenuated caspase mediated killing (Dimmeler et al 1996).  
 Prolonged shear stress causes distinct structural and morphological changes in 
endothelial cells and also affects the overall vascular tone through the regulation of 
various vasoconstrictors and vasodilators. Shear stress is essential to maintain endothelial 
integrity and cardiovascular health.  It has been shown that fluid shear stress plays an 
important role in blood vessel formation and maintenance although the mechanisms are 
not fully understood yet.  
2.3 Shear stress sensors                        
The ability of endothelial cells to respond to shear stress indicates that they can sense 
shear stress as a signal. Various studies have been done to understand the mechanisms of 
signal mechanotransduction in shear stress.  Shear stress is detected by various receptors, 
tranducers and sensor proteins on the cell surface and multiple pathways are involved in 
the shear stress signal transduction including G proteins, tyrosine kinase receptors, 
caveolae and ion channels.               
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Figure 7 – Mechanotransduction of endothelial shear stress (Image taken from 
Chatzizisis et al 2007). 
 
 
Shear stress is sensed by various mechanoreceptors including integrins, caveolae, ion 
channels, G coupled proteins, tyrosine kinase receptors and proteoglycans. Integrins are 
activated when shear stress signals are transmitted through the cytoskeleton to the basal 
endothelial surface. Various other proteins and protein complexes including adaptor 
proteins (Grb2, Crk), non receptor tyrosine kinases (FAK, c-Src, Shc, paxillin, p 130
CAS
) 
and guanine nucleotide exchange factors (Sos and C3G), are phosphorylated and 
activated by the integrins. This activates the Ras family GTPase, which triggers 
downstream cascades of serine kinases, ultimately activating mitogen activated protein 
kinases (MAPKs). Shear stress signals transmitted through the cytoskeleton to the 
junctional or luminal endothelial surface activates protein kinase C (PKC), Rho family 
small GTPases which mediate cytoskeletal remodelling and phosphoinositide 3 kinase 
(PI3K) - Akt cascade. All of these signalling pathways lead to phosphorylation of various 
transcription factors, which bind to shear stress responsive elements (SSPE) at promoters 
of mechanosensitive genes, thereby inducing or suppressing their expression  
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2.4 Shear stress, endothelial dysfunction and atherosclerosis                       
Atherosclerosis is a chronic and inflammatory disease of conduit arteries and is the 
leading cause of death in developed countries. It is associated with several other well 
defined risk factors including hypertension, hyperlipidemia and diabetes mellitus. The 
atherosclerotic lesions
 
form at specific regions of the arterial tree, such as in the
 
vicinity 
of branch points, the outer wall of bifurcations, and
 
the inner wall of curvatures, where 
disturbed flow occurs. It has been widely shown that atherosclerosis preferentially 
develops in vascular regions with low shear (Malek et al 1999; Nerem et al 1993). On the 
other hand, the vessel regions which are exposed to laminar, steady and high shear flow 
remains disease free.           
 Sterol
 
regulatory element binding proteins (SREBPs) are also activated by low 
shear stress. These endoplasmic
 
reticulum-bound transcription factors upregulate the 
expression of genes
 
encoding the LDL receptor, cholesterol synthase, and fatty acid
 
synthase (Liu et al 2002). SREBPs also increase the permeability of the endothelial 
surface to LDL (Traub et al 1998) and production of reactive oxygen species (ROS). The 
circulatory inflammatory cells (monocytes, T lymphocytes and mast cells) are recruited 
into the tunica intima, the innermost layer of the arteries, to scavenge oxidized LDL. 
NFκB is activated which upregulates genes encoding vascular cell adhesion molecule-1 
(VCAM-1), intercellular adhesion molecule-1 (ICAM-1), monocyte chemoattractant
 
protein (MCP)-1; and pro-inflammatory cytokines, such as tumor
 
necrosis factor α (TNF 
α) and interleukin (IL)-1. These adhesion molecules mediate rolling and adhesion of 
leukocytes on endothelial cells. MCP-1 promotes recruitment of leukocytes into the 
intima. After leukocyte infiltration into endothelial cells, they differentiate into 
macrophages, which sustain inflammation and hence promote atherosclerosis.  
 Shear stress is also associated with endothelial proliferation. Endothelial cell 
proliferation increases by 18 times within 48 hours of shear stress reduction (Mondy et al 
1997). Decrease in shear stress also causes vascular smooth muscle cell proliferation, 
differentiation and migration into the intima, endothelial cell loss and decrease in actin 
stress fibres (Walpola et al 1993, 1995).      
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Figure 8 – Effects of disturbed shear rates on endothelial cell function (Image taken 
from Malek et al 1999). 
Hemodynamic shear stress is very important for maintaining endothelial integrity and 
function. Arterial-level shear stress (>15 dyne/cm2) induces endothelial quiescence by 
decreasing proliferation and apoptosis. It also upregulates the expression of 
atheroprotective genes including eNOS. However, low shear stress (<4 dyne/cm
2
), which 
is prevalent at atherosclerosis-prone sites, stimulates an atherogenic phenotype by 
decreasing antioxidants production and atheroprotective genes. Increased expression of 
VCAM and MCP-1 activates the monocytes, enhancing the progression of atherogenesis.  
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2.5 Parallel plate flow chambers                          
To study the dynamic response of vascular endothelial cells to controlled levels of fluid 
shear stress, various types of in vitro systems that allow cultured endothelial cells to be 
exposed to well-defined flow conditions have been developed. These systems include a 
cone-plate apparatus (Dewey et al 1981), orbital shakers (Dardik et al 2005), capillary 
flow tubes (Olesen et al 1988; Jacobs et al 1995), and parallel-plate flow chambers 
(PPFC) (Ruel et al 1995; Chiu et al 1998).        
 Among in vitro systems employed to study the effects of flow conditions on 
endothelial cells, PPFC have been the most commonly used for flow stimulation of 
endothelial cells (Brown et al 2000). PPFC are generally used to mimic shear flow on 
cultured endothelial cells. A typical PPFC consists of a silicon gasket, a polycarbonate 
distributor, which has inlet and outlet ports, and a glass coverslip on which endothelial 
cells are grown. The endothelial monolayer is subjected to fluid flow by creating a 
pressure gradient along the chamber. The design of PPFCs is very simple and they are 
very easy to operate. The main advantage of PPFC is that it can be used to produce shear 
rates ranging from 0.01 – 60 dyne/cm2 and studies can be visualized in real time.  
 Studies using the PPFC have provided insight into the effects of shear on 
endothelial cell alignment and elongation, aided investigators in fine tuning the 
application and adjustment of shear and helped lay the groundwork for future devices.  
For example, endothelial cells have been subjected to steady and pulsatile shear stress to 
measure and correlate their production of prostacyclin
 
(Hanada et al 2000; Grabowski et 
al 1985), determine their orientation with respect to flow direction and reveal that higher 
shear stress results in a higher degree of cell elongation
 
(Levesque et al 1985).  
Mechanotransduction in endothelial cells has been studied using many in vitro and in vivo 
approaches.           
 PPFCs have been used to study the effects of shear stress on the apoptosis of 
HUVECs induced by lipopolysaccharide (LPS) (Zeng et al 2005) and expression of 
proto-oncogenes, c-fos and c-myc in HUVECs (Li et al 2002). The effects of fluid shear 
stress on MCP-1 induction in endothelial cells have also been investigated using PPFCs 
(Yu et al 2002). PPFCs have also been used to study the mechanisms underlying 
proliferation, adhesion and metastasis of cancer cells (Zhang et al 2003).  
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3. Thymosin β 4       
Thymosins are a group of peptides which were first isolated from calf thymus. These are 
divided into 3 different groups based on their isoelectric point: α thymosin (pI < 5), β 
thymosin (5 < pI < 7) and γ thymosin (pI > 7). β thymosins are a family of structurally 
related proteins, which have highly conserved amino acid sequences among different 
species. Thymosin β 10 and thymosin β 15 are expressed in breast, thyroid and prostate 
metastatic tumors and are thought to be the prognostic markers of these cancers (Bao et al 
1996; Santelli et al 1999). There are 16 members of the β thymosin family and thymosin 
β 4 (Tβ4) is the most studied of all the members of the family.   
 Tβ4 is a highly conserved peptide, which was first isolated from thymus tissue in 
1981 (Low et al 1981; Yu et al 1994). It has 43 amino acids with a molecular weight of 
4.9 kDa. It is found in concentrations of 10 nM – 600 M in different tissues and cell 
types (Hannappel et al 1985, 1987). The concentration of free Tβ4 in blood is about 10–
200 nM (plasma and serum). It is regarded as a major intracellular G actin sequestering 
peptide in mammalian cells. It forms a 1:1 complex with G actin and inhibits its salt 
induced polymerization to F actin (Hannappel et al 1993; Huff et al 2001). Tβ4 is also 
present inside the cell and extracellular fluid. 
 
3.1 Structure and properties        
Tβ4 has a dynamic and flexible conformation. Three dimensional structure 
determinations by NMR-techniques have demonstrated that Tβ4 is unstructured in 
aqueous solutions. However, when fluorinated alcohols are added to the aqueous solution 
a defined 3D-structure can be obtained (Zarbock et al 1990). The data obtained under 
these conditions indicated that Tβ4 is a rather extended molecule of almost 5 nm in 
length. Both the N- and C-terminal conserved sequence stretches ranging from residues 5 
to 15 and 30 to 40, respectively, form short α-helices linked by a flexible loop.  
 Proteins which lack a definite secondary structure in aqueous solutions attain a 
defined tertiary structure on binding their target proteins and undergo a number of 
structural intermediate states after forming the initial collision complex (Sugase et al 
2007).  Due to their ability to attain different conformations, such proteins can also 
interact with a number of different proteins. β thymosins might also behave in a similar 
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way. In other words, their binding to actin may induce a stable three-dimensional 
structure with defined secondary structural elements. The ability to adopt different 
conformations might explain the promiscuous protein interactions and multiple 
extracellular functions of β thymosins.       
 
3.2 Biological functions 
Various studies have shown diverse biological roles of Tβ4. It promotes wound repair, 
angiogenesis, cell migration, tissue protection, regeneration in the skin, eyes and heart, 
and prevents apoptosis and inflammation.                                  
 
3.2.1 Tβ4 promotes cell migration and adhesion                                  
The regulation of polymerization and depolymerization of actin subunits is a key 
mechanism by which Tβ4 enables cells to migrate (Malinda et al 1997; Grant et al 1995). 
It also upregulates the gene expression of laminin -5, a subepithelial basement membrane 
protein believed to be one of the best ligands for keratinocyte adhesion and migration, 
and influences cell migration (Sosne et al 2004). Tβ4 also activates Akt, which plays a 
very potent role in cell growth, survival and motility (Bock-Marquette et al 2004). During 
the morphological differentiation of endothelial cells into capillary-like tubes, there is a 
five fold increase in Tβ4 mRNA level. When the endothelial cells are transfected with 
Tβ4, there is an increased rate of attachment and spreading on matrix components and an 
accelerated rate of tube formation on Matrigel (Grant et al 1995). Tβ4 also stimulates the 
migration of HUVECs (Malinda et al 1997) and induces matrix metalloproteinase 2 in 
vitro and in vivo (Malinda et al 1999). Another study indicated that local production of 
Tβ4 is increased during muscle injury and it promotes myoblast migration, hence 
facilitating skeletal muscle regeneration (Tokura et al 2011).                                             
 
3.2.2 Tβ4 prevents apoptosis and promotes cell survival, angiogenesis and cell 
differentiation                        
Tβ4 has been shown to reduce apoptosis and promote induction of anti apoptotic genes. A 
previous study on the pro-apoptotic effects of ethanol on corneal epithelial cells has 
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shown that Tβ4 decreases cytochrome c release from the mitochondria and caspase 
activation. It also increases the expression of anti-apoptotic protein, bcl-2 (Sosne et al 
2004). In cardiomyocytes, it activates the phosphoinositide/Akt cell survival signalling 
pathway and inhibits endothelial apoptosis (Hinkel et al 2008).     
 Tβ4 is known to be an important angiogenic molecule that promotes angiogenesis 
by differentiation and directional migration of endothelial cells (Malinda et al 1997; 
Grant et al 1999). It promotes coronary vessel development and collateral growth during 
embryonic development and also stimulates epicardial vascular progenitors which can 
later differentiate into endothelial and smooth muscle cells (Smart et al 2007). Tβ4 has 
been shown to induce dermal repair and hair growth by promoting stem cell migration 
and differentiation into keratinocytes and hair follicles (Philip et al 2004).  
 
3.2.3 Role of Tβ4 in thrombosis                        
The concentration of Tβ4 is very high in white blood cells and in plasma is very low, 
however during blood clotting, Tβ4 concentration in the serum increases substantially. In 
1987, it was shown that Tβ4 is present in human blood platelets in very high 
concentrations (Hannappel et al 1987). In resting platelets, the Tβ4 concentration is ~ 
560µM, of which ~ 280µM is in complex with G actin and ~280µM is free (Nachmias et 
al 1993).           
 During blood coagulation or ADP induced aggregation of platelets Tβ4 is 
liberated from platelets and partially cross-linked to fibrin by a transglutaminase, factor 
XIIIa (Huff et al 2002). Tβ4 crosslinking to the fibrin occurs in a time and Ca2+ 
dependent manner. Factor XIIIa incorporates Tβ4 preferentially into the fibrin αC-
domains, a domain often used to attach biologically active peptides to fibrin 
(Makogonenko et al 2004). The covalent cross-linking of Tβ4 to the fibrin clot might 
represent a mechanism to guarantee a high local concentration of the peptide at the site of 
injury probably supporting subsequent wound healing.  This could be a potential 
molecular mechanism to bring Tβ4 near the site of vascular injury and leads to clotting 
and wound repair by Tβ4. 
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Figure 9 – Tβ4 and blood coagulation (Image taken from Huff et al 2002). 
 
When the platelets are stimulated with ADP, various cytoskeletal changes take place. The 
platelets change shape and there is secretion of ADP, Factor V, Tβ4, serotonin, 
thromboxane A2 and growth factors. The platelets aggregate and form a platelet plug, 
which must be stabilized by a fibrin clot to ensure wound closure. The fibrin monomers 
attach to the platelet plug and are further cross linked by factor XIII to form an insoluble 
clot. Tβ4 released from the platelets is also fixed to the fibrin clot by factor XIII  
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3.2.4 Role of Tβ4 in inflammation and corneal wound healing and repair                     
Previous studies have shown that Tβ4 decreases inflammation and promotes corneal 
wound healing. It decreases matrix metalloproteinases and proinflammatory cytokines 
and chemokines. In mouse models, topical application of Tβ4 after alkali injury 
downregulates the expression of the potent chemoattractants, macrophage inflamatory 
protein 2 (MIP 2) and keratinocyte chemoattractant (KC) in the cornea (Sosne et al 2002). 
It also accelerates epithelial cell migration and re-epithelialization after alkaline and 
alcohol injuries and scrape wounding in a dose-dependent manner in rat corneal wound 
models (Sosne et al 2002, 2005). Tβ4 has been shown to protect corneal endothelial cells 
from apoptosis and oxidative stress induced by low dose ultraviolet B (UVB) exposure 
(Ho et al 2010). It protects human corneal epithelial cells against Fas ligand (Fas-L) and 
H2O2 induced damage. Internalization of Tβ4 is critical for its cytoprotective effect (Ho et 
al 2007).          
 Tβ4 is hypothesized to be an anti-inflammatory agent. It interferes with the NFκB 
signalling pathway, which is activated by the potent pro-inflammatory cytokine TNFα. 
Tβ4 pre treatment reduces nuclear NFκB protein levels, NFκB activity, and p65 subunit 
phosphorylation, and nuclear translocation in corneal epithelial cells stimulated with TNF 
α (Sosne et al 2007). No receptors have been identified for Tβ4 thus far. Future 
investigation of putative Tβ4 receptors would provide critical information for 
understanding how extracellular Tβ4 exerts its biological activities in cells.                                             
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4. Retinal Pigment Epithelium      
Retinal pigment epithelium (RPE) is a monolayer of pigmented cuboidal cells present 
between the retinal photoreceptors and choriocapillaris. It is separated from the 
choriocapillaris, which supplies blood flow to the RPE, and the outer one-third of the 
retina (including the photoreceptors), by Bruch’s membrane. The human RPE 
incorporates approximately 3.5 million epithelial cells arranged in a regular hexagonal 
pattern. RPE are bound together by junctional complexes with prominent tight junctions. 
These junctions divide the cells in an apical half that faces the retina and a basal half that 
faces the choroid (Hudspeth et al 1973). The only anatomical contact between the 
photoreceptors and RPE is the interphotoreceptor matrix. Under pathological conditions 
such as retinal detachment, fluid accumulates in the subretinal space and photoreceptors 
are separated from the RPE. This causes a loss of photoreceptor function.  
 The embryonic development and differentiation of RPE and photoreceptors is 
interrelated. Both photoreceptors and choriocapillaries depend on the RPE for their 
survival. RPE is crucial for the development of the retina. It secrets various growth 
factors required for photoreceptor differentiation and survival. It has been shown in an 
animal model of retinal dystrophy, that RPE secretes basic fibroblast growth factor 
(bFGF), which promotes the survival of photoreceptors (Faktorovich et al 1990). 
Neuronal retina and photoreceptors are affected the most by RPE loss.   
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Figure 10 – Retinal pigment epithelium. (Image taken from www.dev.ellex.com) 
 
 
4.1 RPE Functions              
RPE is involved in a variety of functions which includes phagocytosis of shed outer 
segments, transport of vitamin A to the photoreceptors and maintenance of normal 
physiology of the choriocapillaries (Bok et al 1993). RPE transports electrolytes and 
water from the subretinal space to the choroid, also transports glucose and other nutrients 
from the blood to the photoreceptors.  
                                                      
a) Light absorption – RPE increases optical quality by helping in absorption of the 
scattered light. RPE pigmentation is very critical to maintain visual function. It contains a 
complex composition of various pigments (melanin, lipofuscin) which absorb different 
wavelengths of light. Melanin is the main pigment of RPE present within cytoplasmic 
granules called melanosomes. It absorbs stray light and minimizes light scattering within 
the eye. The retina has a direct and frequent exposure to light which causes the photo-
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oxidation of lipids, which can be extremely toxic to retinal cells (Girotti et al 2004). The 
retina also generates large amounts of reactive oxygen species (ROS) due to its high 
oxygen consumption. RPE counterbalances the high oxidative stress present in the retinal 
cells by maintaining large amounts of enzymes like superoxide dismutase (SOD) and 
catalase (Frank et al 1999; Tate et al 1995) and non enzymatic antioxidants like 
ascorbate, lutein and zeaxanthin (Newsome et al 1994; Beatty et al 2000), which act as a 
defence system against the oxidative stress.   
 
 b) Transport nutrients and ions – RPE transports nutrients like glucose, retinol and 
fatty acids from blood to the photoreceptors. It has large numbers of glucose transporters 
GLUT 1 and GLUT 3 in its apical and basolateral membranes (Ban et al 2000). With the 
help of these glucose transporters, RPE transfers glucose from the blood to the 
photoreceptors. GLUT1 induces glucose transport in response to mitogens and hence 
adapts glucose transport according to the metabolic needs of the retina. During the visual 
cycle, the bulk of retinal is exchanged between RPE and the photoreceptors. The RPE 
takes all-trans retinol from the photoreceptors, oxidizes and isomerizes it to 11-cis retinal 
and redelivers it to the photoreceptors (Baehr et al 2003). Docosahexaenoic acid (DHA) 
is an essential omega 3 fatty acid which is required as a structural element of 
photoreceptor and neuron membranes, however, DHA cannot be synthesized by the 
neural tissues and is hence transported by RPE from blood to the photoreceptors 
(Anderson et al 1992).                        
 Due to the high metabolic turnover in the photoreceptors, a large amount of water 
is produced in the retina. Also, there is movement of water from the vitreous body to the 
retina due to intraocular pressure (Marmor et al 1990; Hamann et al 2002). Hence, there 
is a constant need for removal of water from the retina. RPE transports water and ions 
from the subretinal space to the blood (Hughes et al 1998). It also eliminates metabolic 
end products of the photoreceptors. Photorecpetor outer segments produce lactic acid and 
its subretinal concentration is estimated to be around 19 mM (Adler et al 1992; Hsu et al 
1994). RPE removes lactic acid from the subretinal space through lactate-H
+
 
cotransporter MCT1 (Lin et al 1994; Philip et al 1998) and Na
+
 dependent transporter for 
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organic acids (Kenyon et al 1994). The Na
+
-K
+
-ATPase, which is located in the apical 
membrane, provides the energy for transepithelial transport (Marmorstein et al 2001).  
                                                
c) Phagocytosis – When the photoreceptors are exposed to high intensities of light, there 
is an increase in concentration of light induced toxic substances like photo oxidative 
radicals and photo damaged proteins and lipids, in the photoreceptors (Beatty et al 2000). 
To maintain the excitability of the photoreceptors, the photoreceptor outer segments 
undergo a constant renewal process (Young et al 1969; Nguyen-Legros et al 2000). The 
highest concentration of these toxic substances is present in the tips of the photoreceptor 
outer segments. Hence, these tips are shed from the photoreceptors and new tips are 
formed from the base of outer segments, at the cilium. The shedding of tips and the 
formation of new tips is very well coordinated, so that the length of photoreceptor outer 
segments is maintained. The shed tips are phagocytosed and digested by RPE. Retinal and 
docosahexaenoic acid are transported back to the photoreceptors to rebuild the outer 
segments (Bok et al 1993; Bibb et al 1974).                         
 
d) Secretion – RPE secretes a large number of growth factors which are essential for the 
maintenance of the structural integrity of the retina. It secretes fibroblast growth factors 
(FGF-1, FGF-2 and FGF-5), insulin like growth factor-1 (IGF-1), VEGF, pigment 
epithelium derived factor (PEDF), platelet derived growth factor (PDGF) and lens 
epithelium derived growth factor (LEDGF).        
 Although VEGF is secreted in very low quantities by RPE, it plays an important 
role in maintaining intact endothelium of the choriocapillaries (Adamis et al 1993; Burns 
et al 1992). A neuroprotective factor PEDF secreted by RPE protects neurons against 
glutamate and hypoxia induced apoptosis (Cao et al 2001). It stabilizes the endothelium 
of choriocapillaries (King et al 2000) and plays an important role in the embryonic 
development of the eye (Behling et al 2002).  Another peptide secreted by RPE is 
somatostatin, which plays an important role in retinal homeostasis. Somatostatin acts as a 
neuromodulator through different pathways including intracellular calcium signalling 
(Johnson et al 2001) and glutamate release from the photoreceptors (Akopian et al 2000).              
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e) Retinoid cycle – One of the most important functions of RPE is its role in the visual or 
retinoid cycle, which involves repeated movement of retinoid and its derivatives between 
photoreceptors and RPE (Bok et al 1993). The light is absorbed by rhodopsin, which is 
composed of the G-coupled receptor protein opsin and chromophore 11-cis –retinal. After 
light absorption, 11-cis-retinal is converted into all-trans retinal. The photoreceptors lack 
cis-trans isomerase function for retinal and are unable to regenerate 11-cis-retinal from 
all-trans-retinal. The main purpose of the visual cycle is to regenerate 11-cis retinal, 
which acts as a chromophore for the visual pigments of outer segments of photoreceptors. 
All-trans-retinal is reduced to all-trans-retinol and is transported to RPE. The 
isomerisation is the first step in phototransduction and takes place in RPE. In RPE, retinol 
is oxidized and reisomerized to 11-cis-retinal by the enzyme retinal pigment epithelium-
specific proten (RPE65) and is delivered back to the photoreceptors (Hargrave et al 2001; 
Pang et al 2006; Bernstein et al 1987). Interphotoreceptor retinoid binding protein (IRBP) 
mediates the transport of retinoids between RPE and photoreceptors. IRBP is a large 
glycoprotein present in the RPE endosomes and interphotoreceptor matrix (IPM) 
(Cunningham et al 2003; Wu et al 2007; Gonzalez-Fernandez et al 2008). IRBP 
solubilises retinal and retinol and mediates the direction of transport of these compounds 
(Okajima et al 1989; Pepperberg et al 1991).                         
                      
 
4.2 RPE ageing and diseases                          
A variety of structural and biochemical changes occur in RPE with increasing age. There 
is increase in atrophy, hyperpigmentation and loss in cell shape. With advancing age, 
there is also a decrease in the concentration of RPE cells in the posterior pole. The 
melanin content of RPE also decreases with age (Salvi et al 2006). Senescent RPE 
accumulate metabolic debris from remnants of incomplete degradation of phagocytized 
rod and cone membranes (Ciulla et al 2001). Ingestion of outer segments of 
photoreceptors puts a heavy phagocytic burden on RPE, which results in the 
accumulation of lipofuscin between RPE and Bruch’s membrane. Lipofuscin is an 
undegradable byproduct of outer segment photoreceptor metabolism which increases in 
RPE over time. The accumulation of lipofuscin is involved in the pathogenesis of various 
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retinal diseases like age related macular degeneration (AMD) and is one of the major 
characteristic features of ageing in RPE. Lipofuscin is continuously exposed to light and 
high oxygen tension, which leads to production of reactive oxygen species (ROS) and 
causes oxidative damage to mitochondria and mitochondrial DNA. The production of 
antioxidants, which RPE produces to counteract oxidative stress, also decreases with age 
(Liang et al 2003). Mitochondrial damage affects the cellular and physiological 
functioning of RPE. This leads to decrease in energy production and subsequently signals 
apoptosis eventually decreasing the number of RPE (Zarbin et al 2004).   
 Under normal conditions, RPE secretes various growth factors which can protect 
photoreceptors from damage. There is constant balance between angiogenic and anti-
angiogenic growth factors within the eye. Imbalance between the secretion of these 
growth factors leads to choroidal neovascularisation (Bhutto et al 2006). PEDF and 
VEGF are two growth factors secreted by RPE, which cross regulate each other. VEGF 
gene expression increases angiogenesis whereas PEDF acts as an antagonist and inhibits 
angiogenesis (Tsai et al 2006; Dawson et al 1999). To regulate angiogenesis in the retina, 
balance between these two growth factors is very essential (Tong et al 2006). Previous 
studies have shown that VEGF is upregulated in RPE and choroid complex in patients 
suffering from AMD (Tsai et al 2006). Decreased PEDF levels in the vitreous samples of 
AMD patients have also been reported (Holekamp et al 2002).    
               
 
4.2.1 Age related macular degeneration (AMD) – AMD is the major cause of blindness 
in elderly people. The atrophic or dry form of AMD is caused by progressive degradation 
of RPE and the photoreceptors. In AMD, vision loss occurs as a result of photoreceptor 
damage in the central retina; however the initial pathogenesis involves RPE degeneration 
(Zarbin et al 1998). Since RPE is involved in the metabolic and nutritional aspects of the 
photoreceptors, RPE dysfunction can cause secondary degeneration of the photoreceptors. 
Age-related processes that occur in the retinal pigment epithelium-Bruch’s membrane-
choriocapillaris complex can precede the development of AMD (Liang et al 2003). AMD 
is associated with an accumulation of lipofuscin, a pigment formed in tissues with high 
levels of oxidative stress. Early AMD is characterized by thickening and loss of normal 
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architecture within Bruch’s membrane, lipofuscin accumulation in the RPE, and drusen 
formation beneath the RPE in Bruch’s membrane. The primary clinical characteristic of 
late stage dry AMD is the appearance of RPE atrophy. It is characterized by roughly oval 
areas of hypopigmentation and is usually the consequence of RPE cell loss. Loss of RPE 
cells which provide nutrition to the photoreceptors leads to the gradual degeneration of 
nearby photoreceptors, resulting in a progressive visual impairment.                        
 
4.2.2 Retinitis pigmentosa – Retinitis pigmentosa is an inherited form of retinal which is 
characterized by pigment deposits in the retina. It involves degeneration of photoreceptors 
rods and cones and deposits in the retinal pigment epithelium. The accumulation of 
metabolic waste products lead to lipofuscin formation which affects the function of the 
RPE. The inability of RPE to phagocytose photoreceptor outer segments causes an 
autosomal recessive form of retinitis pigmentosa (Edwards et al 1977; Wang et al 2001). 
 
4.2.3 Diabetic retinopathy – Diabetic retinopathy (DR) is one of the leading causes of 
blindness in developed countries. DR is characterized by decreased levels of glutathione, 
SOD and ascorbic acid (Madsen-Bouterse et al 2008; Silva et al 2009; Minamizono et al 
2006). A recent study has shown that there is a decrease in IRBP production in early 
diabetic retinopathy (Garcia-Ram´ırez et al 2009). IRBP is required for retinoid transport 
between RPE and photoreceptors and is critical for the visual cycle.    
 Increased production of VEGF, an angiogenic factor, plays an important role in 
the pathogenesis of DR. There is a decreased expression of the anti-angiogenic factor, 
PEDF, by elevated glucose concentration in cultured human RPE cells (Yao et al 2003). 
New therapeutic approaches for DR which involve blocking VEGF and stimulating PEDF 
have been proposed. The development of DR is also favoured by the decreased 
expression of somatostatin (Carrasco et al 2007). Somatostatin plays an important role in 
preventing neovascularisation and fluid accumulation within the retina. These functions 
are greatly impaired due to downregulation of somatostatin expression, thus leading to 
development of DR (Hern´andez et al 2005; Sim et al 2007). 
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  CHAPTER 2 
 
Development of flow device to study effects of shear stress on 
endothelial cells and its applications 
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Introduction 
 
Endothelial cells are exposed to various mechanical stimuli such as shear stress, 
hydrostatic pressure and cyclic stretch due to vessel deformation. These stimuli alter 
endothelial cell morphology, initiate cytoskeletal changes and activate various signalling 
pathways. The nature and magnitude of these hemodynamic forces has an important role 
in maintaining vascular homeostasis. 
Laminar shear stress is one of the most potent endothelial stimulators, which is 
very critical for normal vascular functioning. It plays an important role against 
inflammatory activation and apoptosis (Tricot et al 2010; Chien et al 2008). Disturbed 
shear stress has been implicated in the pathogenesis of various diseases including 
atherosclerosis and cardiovascular diseases (Traub et al 1998). 
In the past few years, physiological and pathological shear stress has been studied 
extensively to understand the development and progression of vascular diseases. To 
understand the effects of these hemodynamic forces in vitro, engineered devices are 
required that can maintain the endothelial cells in a controlled in vivo like environment. 
The fluid flow must be predictable in these devices so that shear stress over endothelial 
cells can be properly controlled.  
Many in vitro flow systems have been developed to study endothelial cells under 
shear stress. These flow devices require a large population of endothelial cells which 
needs more chemicals and reagents. Recently, many studies have reported the 
development of microfluidic flow chambers. Some of these designs have multiple 
microchannels to study different cell types and shear rates at the same time (Young et al 
2007). A major drawback of such flow devices is cross contamination between different 
channels. Some of these flow devices and microfluidic devices have been custom 
laboratory prototypes, while others are commercially available. 
In the present study, we describe the construction and testing of a simple and 
robust parallel plate flow chamber. The aim of this study was to develop an in vitro model 
using a parallel-plate flow chamber to simulate in vivo fluid shear stresses on endothelial 
cells exposed to dynamic fluid flow in their physiological environment. A computational 
fluid dynamics (CFD) template was developed for simulation and prediction of flow 
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induced shear rates on the endothelium, while an in vitro model was used to investigate 
the subsequent cellular biological responses. 
The flow chamber was validated by determining changes in the production of 
nitric oxide and caveolin-1 expression in bovine endothelial cells exposed to shear stress. 
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Experimental Methods 
Cell culture 
Bovine aortic endothelial cells (BAECs) were purchased from Coriell Institute for 
Medical Research. The cells were cultured in DMEM F-12 media containing 10% fetal 
calf serum (FCS, Gibco) and penicillin-streptomycin, at 37°C in a humidified atmosphere 
of 95% air and 5% CO2. 
 
Parallel plate flow chamber configuration 
The flow apparatus used in this study is a parallel plate flow chamber with a closed loop 
system (Figure 1). 
 
CFD simulation and viscosity measurement 
In order to use the velocity gradient templates as shear stress templates, the viscosity of 
the media at 37ºC was required.  A viscometer (Canon Instruments, Model 2085, PA, 
USA) and viscosity bath, set to 37ºC, were used.  The media was injected into the 
viscometer and allowed to reach equilibrium conditions before being suctioned to the top 
of the viscometer and then released while the time it takes the fluid to flow through a 
defined section was measured.  Using equipment specific correlations, the viscosity was 
calculated based on the time taken to pass through a defined section.  This process was 
repeated five times and an average viscosity was calculated and used in the shear stress 
calculations.  The specific gravity of the media was determined by using a calibrated 
hydrometer.  The average viscosity was 0.753 cP (0.00753 Pa∙s). 
 
Calculation of shear stress 
Shear stress was calculated according to the following formula: 
    
d z
d y
   
Where μ is the viscosity of the media and dy/dz is the velocity gradient of the flow.  From 
the templates generated in FLUENT the values of the velocity gradients at various 
regions on the plate are known.  Since the viscosity of the media has been measured, the 
shear stress can be directly calculated and an average shear stress for each region on the 
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template can be defined.  The shear stress values used in our investigations ranged from 
0.05 to 1.47 Pa, which is within the physiological range for aortas (~0.002 Pa) and veins 
(~0.01 Pa).     
 
Shear stress studies 
Bovine endothelial cells were grown on coverslips in 35mm cell culture plates. The cells 
were exposed to shear stress using a peristaltic pump (Reglo Digital MS 4/6, model ISM 
833, Ismatec).  PTFE tubing (Scientific Products & Equipment, Canada) was used to link 
the pump and the flow chamber. Shear stress experiments were performed for 16 hours in 
complete media in 5% CO2 incubator at 37°C. 
 
Measurement of NO production 
To determine changes in NO production, endothelial cell monolayers were incubated with 
cell culture medium containing 5 M 4,5-diaminofluorescein diacetate (DAF-DA , 
Invitrogen) at 37°C in a 95% air/5% CO2 incubator for 30 min. Cells were then washed 
3X with phosphate buffered saline (PBS) and mounted on the stage of an Axiovert 200 
inverted fluorescence microscope. DAF-DA fluorescence was monitored using excitation 
and emission wavelengths of 485 and 538 nm, respectively.     
 BAECs were grown under shear stress and static cells were used as control. After 
incubation for 24 hours, media containing 100µM of acetylcholine was injected into the 
flow chamber. The cells were incubated again and after 1 hr, 200 uL of media was 
withdrawn with a Hamilton gastight syringe and directly injected into the purge vessel of 
a Sievers Nitric Oxide Analyzer (Model 280i) which contained acetic acid and sodium 
iodide.  
  
Immunofluorescence 
BAEC cells were grown on coverslips in 35mm cell culture dishes. The cells were grown 
under shear stress for 16 hours and static cells were used as control. After incubation, the 
cells were washed with PBS and fixed in 3% paraformaldehyde for 10 min. The cells 
were then permeabilized with 0.025% Triton X for 10 min. Rabbit polyclonal antibody 
against Ser 1177 phospho eNOS (1:200 dilution; Cell Signal) and anti-mouse caveolin-1 
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(1:100) were used as primary antibodies. Alexa Fluor 488 -labelled goat anti-rabbit IgG 
and Alexa Fluor 568 conjugated anti-mouse IgG were used as a secondary antibodies 
(1:500 dilution; Molecular Probes, Canada). Cells were also stained with either propidium 
iodide (PI) or DAPI for the localization of nuclei. Preparations were mounted in 
fluoromount G (Southern Biotech) and examined by fluorescence microscopy.  
 
Statistical analysis 
Data is expressed as an average of all trials and statistical analysis was done by Student’s 
t test. The quantification of the fluorescence intensity was done using Image J software.  
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 Results 
Flow chamber 
The parallel plate flow chamber described herein was designed to minimize solution 
volumes, to be operationally robust and precise, simple to set up, and inexpensive.  Also 
critical to the design was the ability of the chamber to be mounted on a microscope stage 
to facilitate visualization experiments. The chamber pictured in Figure 1 is 64 mm in 
diameter and 28 mm in height.  It was machined out of surplus aluminum and acrylic 
stock.  The unit consists of three principal elements, an inner acrylic “puck” that forms 
the chamber, an interchangeable gasket that creates the channel geometry, and an 
aluminum clamping fixture that holds it all together. A special low cost thermoset plastic 
has been adapted for use as a chamber gasket.  A simple series of die punches provide a 
variety of channel geometries.  The unit can also accept commercially available gaskets 
like those produced by Glycotech (Rockville Maryland).  Channel depth is set by the 
clamping fixture and the thickness of gasket utilized. The two halves of the clamping 
fixture thread together to compress the gasket to provide the chamber seal.  To ensure 
proper channel depth, two interchangeable locator pins prevent the fixture from being 
over tightened. Inlet and outlet ports were machined into the top of the acrylic chamber.  
Each is threaded to accept standard commercially available fittings.  The ports are 
chamfered with a smooth Gaussian shaped profile to minimize flow disturbances during 
flow entrance and exit. 
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Assembled Chamber
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Figure 1 – Schematic diagram of the parallel plate flow chamber. 
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Computational fluid dynamics 
To simulate the flow in the chamber and estimate the shear stress for the testing program, 
a computational model of the flow channel was developed. The commercial finite volume 
solver, Fluent 6.1 was utilized for this study.  Free outflow and mass flow inlet boundary 
conditions were assumed at the outlet and inlet of the channel respectively in the steady, 
laminar simulation.  The material properties of the solution were approximated to be that 
of water.  The inlet/outlet ports and flow channel [19 mm long X 5 mm wide X 0.25 mm 
deep] was discretized by tetrahedral elements. Three mesh densities were tested, 
consisting of 83,000, 196,000, and 454,000 elements. Values of the flow velocity 
assessed at 5 locations across the domain changed by no more than 2% when the mesh 
density increased from 196,000 to 454,000.  Thus the medium mesh density was chosen 
for the test runs.   
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Figure 2 – Velocity gradient template. 
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Validation of the flow chamber 
In the present study, we first examined the morphological changes of endothelial cells 
associated with exposure to physiologically relevant shear stress using this flow chamber. 
Bovine aortic endothelial cells were either maintained in static condition or exposed to 
laminar flow at a shear stress of 5 dyne/cm
2
 for 16 h. As shown in Figure 3, fluid shear 
stress induced dramatic morphological changes such as cell elongation and alignment 
with the direction of flow. In contrast, there is no significant cell orientation in cells under 
static conditions.          
  
 
 
 
                                       Control                                      5 dyne/cm
2
 
 
Figure 3 – Effect of shear stress on morphology of bovine endothelial cells. Bovine 
aortic endothelial cells were maintained either under static conditions or under shear 
stress (5 dyne/cm
2
). After incubation for 16 hours, the morphological changes were 
visualized using 20X objective of a Zeiss Axiovert 200 microscope. 
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Nitric oxide production and eNOS phosphorylation in response to shear stress 
In order to validate whether this flow chamber can be employed for studies in the areas of 
biomedical research, the effect of fluid shear stress on nitric oxide production in 
endothelial cells was examined. In the present study, nitric oxide production in bovine 
aortic endothelial cells was determined by a membrane-permeable fluorescent probe 4, 5-
diaminofluorescein diacetate (DAF-2 DA). A significant upregulation (~ 3.6 fold) of NO 
was observed in endothelial cells which were exposed to laminar flow at a shear stress of 
5 dyne/cm
2
 for 16 hours, compared with those maintained in static condition (Fig. 4 A, 
B). A qualitative examination of the  data revealed that nitric oxide production increased 
by 7 fold as compared to the static cells when the endothelial cells were exposed to a 
shear rate of 15 dyne/cm
2 
(Fig. 4 A, B). A significant upregulation (~ 2.5 fold) of 
authentic NO (as determined with NO analyzer) was also observed in endothelial cells 
which were exposed to laminar flow at a shear stress of 5 dyne/cm
2
 for 16 hours, 
compared with those maintained in static condition (Fig. 4C). 
 
 
 
 
 
 
 
 
 
 
 
 
 
62 
 
 
Control    5 dyne/cm
2
   15 dyne/cm
2
 
 
 
 
 
 
 
0
10
20
30
40
50
60
70
Control 5 dyne/cm2 15 dyne/cm2
D
A
F
-D
A
 f
lu
o
re
s
c
e
n
c
e ***
***
A 
B 
C 
63 
 
 
   
Control      5 dyne/cm
2
 
 
 
Figure 4 – Nitric oxide production and eNOS phosphorylation in response to shear 
stress.  (A) The bovine endothelial cells grown under static conditions and shear stress 
for 16 hours were incubated with 5µM DAF-DA for 30 min. The cells were washed with 
PBS and viewed under Zeiss Axiovert fluorescence microscope using 20X objective. (B) 
The graph represents average of DAF-DA fluorescence taken from 4 independent 
experiments (± SD). *** P < 0.001 (C) Total nitrite was measured in control cells and 
cells under shear stress using NO analyzer. The bovine endothelial cells were grown 
under shear stress for 16 hours after which the cells were stimulated with acetylcholine 
for 1 hour and total nitrite was measured. The data shown is average of 3 independent 
experiments (± SD). (D) The cells maintained under static conditions and exposed to 
shear stress for 16 hours were fixed with paraformaldehyde and incubated with anti-rabbit 
Ser1177 phospho eNOS antibody. Alexa Fluor 488 conjugated anti-rabbit IgG was used 
as secondary antibody and the nuclei were stained with PI. The slides were viewed under 
oil immersion 40X objective. (E) Average gray values (immunofluorescence intensity) of 
phospho eNOS levels in static and shear stress exposed cells. The values (average ± SD) 
were calculated from at least 10 different microscopic fields in each slide (n=3). *** P < 
0.001. 
D 
E 
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Change in caveolin-1 expression after shear stress induction      
 
The changes in caveolin-1 expression and distribution were determined by indirect 
immunofluorescence. As shown in Fig. 5, the cells exposed to shear stress showed a ~ 2.7 
fold increase in caveolin-1 expression as compared to static cells. In static cells, caveolin-
1 is present mostly in the plasma membrane, whereas in cells under shear stress caveolin-
1 is also found in the cytoplasm.  
        
 
 
                           Control                                      5 dyne/cm
2
 
 
 
Figure 5 – Shear stress upregulates caveolin-1 expression in bovine endothelial cells. 
(A) BAECs were exposed to shear stress for 16 hours and static cells were used as 
controls. Caveolin-1 expression and distribution (red) was determined by indirect 
immunofluorescence. The nuclei were stained with DAPI (blue). The images were taken 
by 40X oil emersion objective using Zeiss Axiovert 200 microscope. (B) Average gray 
values (immunofluorescence intensity) of caveolin-1 levels in cells maintained under 
static and shear stress. The values (average ± SD) were calculated from at least 10 
different microscopic fields in each slide (n=3). *** P < 0.001. 
A 
B 
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Discussion 
 
Parallel plate flow chambers have been used for years in the study of hemodynamics and 
cellular mechanotransduction (Frangos et al 1985; Levesque et al 1985; Galbraith et al 
1998; McCann et al 2005; Bacabac et al 2005).  The majority of chambers documented in 
the literature were developed for specific research applications and were not mass-
produced for commercial use. The bulk of chambers presently available off the shelf can 
cost upwards of $500 for a pump-ready apparatus. They often require the use of a vacuum 
line or pump and delicate gaskets to maintain chamber seals and prevent leaks.   
This flow device introduced in this study provides a leak proof and contamination 
free environment to the cells. It can also be used for real time monitoring of the live cells, 
to study the dynamics of endothelial cell response to shear. The materials used for making 
this flow device are chemical resistant. Advantages of this system include its simplicity of 
use and small number of cells required to run a simulation. The fabrication is convenient, 
versatile and economical.        
 The reorganization of the endothelial cell morphology is one of the earliest 
responses in the endothelial cells that are exposed to fluid shear stress. Previous in vivo 
and in vitro studies have shown that the endothelial cells elongate and align parallel to the 
direction of flow (Azuma et al 2001; Wojciak-Stothard et al 2003). Our results also 
showed change in morphology of the endothelial cells, which are in agreement with the 
previous reports by other groups (Topper et al 1999; Wang et al 2001; Kadohama et al 
2006).           
 Shear stress is one of the most important physiological stimuli which modulate 
many physiological and pathological processes associated with endothelium, such as 
inflammatory response, vasodilation and endothelial cell proliferation (Davies et al 1995). 
It acts as a potent stimulus for endothelium-dependent NO production and vasodilation 
(Kuchan et al 1994).          
 An important step in the validation process was to determine whether our flow 
chamber was able to discern different shear rates. BAECs were exposed to two different 
shear rates (5 & 15 dyne/cm
2
) and changes in NOx production in response to shear stress 
were determined. There was a ~ 3.5 fold increase in NOx production at 5 dyne/cm
2
 and a 
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7 fold increase at 15 dyne/cm
2 
as compared to the static cells. These results suggest that 
this flow chamber can be utilized to attain different shear rates. These findings are also in 
agreement with numerous previous studies which demonstrated nitric oxide upregulation 
in response of laminar shear stress (Andrews et al 2010; Yang et al 2007).   
 Previous studies have shown that increase in shear stress increases eNOS activity 
by phosphorylation of eNOS at serine 1177 (Corson et al 1996; Dimmeler et al 1999). 
The results of this study also illustrated increase in phosphorylation of eNOS at Ser 1177 
by 2.3 fold. 
Caveolae are small cell surface plasma membrane invaginations, which have 
important role in cell signaling and cholesterol homeostasis. Cholesterol binding protein 
caveolin-1 is the main marker of caveolae. Caveolin-1 could mediate the transfer of 
newly synthesized cholesterol from the ER to the plasma membrane (Smart et al 1996). 
Our results are also in agreement with a previous study which has shown that laminar 
shear stress increases caveolin-1 expression and it also changes the localization of 
caveolin-1 (Sun et al 2002). 
 
Conclusions                         
In conclusion, we have introduced a parallel plate flow chamber for shear stress studies in 
vitro. The data provides robust evidence that this parallel plate flow chamber can be used 
as an effective in vitro system to study the effects of fluid shear stress on the structure and 
function of endothelial cells. The flow rates can be precisely controlled in this laminar 
flow chamber to induce normal stress and shear stress so as to simulate the hemodynamic 
environment of human arteries in vivo.  
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CHAPTER 3 
 
Real-time kinetic analysis of platelet function in a flow 
chamber with matrix proteins covalently attached onto a 
polydimethylsiloxane surface. 
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Introduction 
 
Platelet adhesion and aggregation is the first step in the physiological defence mechanism 
of the body in blood vessel injury. Exposure of extracellular matrix at the sites of sub 
endothelial disruption leads to the capture of platelets to the matrix through various 
receptors including GPIb-IX-V and GPVI, resulting in platelet activation, followed by 
thrombi formation. Shear forces generated by blood flow play an important role in 
platelet adhesion and hence vascular hemostasis.       
 Several investigations on platelet function have focused on the platelet adhesion to 
various matrices (fibrinogen, collagen) under flow conditions. In all of these studies, glass 
slides are coated with fibrinogen, collagen or vWF etc (Turner et al 2001; Remijn et al 
2002)
 
and then used to study platelet aggregation mechanisms. Numerous devices 
including parallel plate flow chambers, which mimic the in vivo conditions (Goncalves et 
al 2003),
 
are available for platelet aggregation studies under various physiological 
conditions. Some of these flow devices and microfluidic devices have been custom 
laboratory prototypes, while others are commercially available. There is currently little to 
no availability of simple, reliable, robust, and inexpensive flow chambers for use in 
kinetic aggregation studies. 
 
Table 1 – Devices available to study platelet aggregation in vitro. 
 
 
Device Advantages Disadvantages Kinetic/Static 
Cone and plate 
viscometer 
High shear rates can 
be attained 
Real time analysis 
not possible 
Static 
Parallel plate flow 
chamber 
Easy to use and 
manufacture, 
Cannot be easily 
modified, requires 
sizable volumes of 
reagents 
Kinetic 
Microfluidic devices Real time imaging, 
less sample volumes 
and cells required 
Costly Kinetic 
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In the present study, we describe the construction and testing of a parallel plate flow 
chamber, which fits onto an inverted microscope and permits the optical monitoring of 
the binding of fluorescently-labelled platelets, in whole blood, onto platelet-binding 
proteins covalently attached to a small area (~0.8 mm
2
) on the flow-device’s surface 
under in vivo-like conditions.  The flow device was validated by comparing the kinetics 
of adhesion of resting as well as Ca
2+
- and ADP-activated platelets from normal and type 
2 diabetic subjects onto fibrinogen and collagen covalently attached to the flow devices.  
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Experimental methods  
Subject selection                            
Healthy human subjects (n=5), ages 25-40 years were chosen to participate in the study 
only if they showed no overt symptoms of disease and were taking no medication. 
Diabetic human subjects, ages 25-40 (n=5) on diet therapy alone and achieving stable and 
satisfactory glycemic control (fasting glycemia and glycosuria variation <15%; post-
prandial glycemia variation<25% and HbA1c<7.5%) were chosen for inclusion in the 
study. None of the patients smoked, had history of alcohol abuse or were taking insulin or 
any drugs known to lower lipids or interfere with the coagulation and antioxidant 
systems. The experimental protocols were approved by the University of Windsor 
Research Ethics Board.                     
 
Construction of flow chamber                       
The flow chamber consisted of a Teflon boundary sealed with 1.5cm microscope 
coverslips (Figure 1 A). The walls of the flow cell were made of polydimethylsiloxane 
(PDMS) (Sylgard 184, Dow Corning). A layer of PDMS, ~ 0.96m thick, was poured on 
the bottom of the chamber.                 
 
Plasma Oxidation of PDMS                         
To generate silanol groups on inert PDMS (Miyaki et al 2007)
 
(Figure 1 B), plasma 
oxidation was carried out using a Plasma cleaner PDC-32G (Harrick Plasma, USA).   
 
Protein immobilization chemistry                       
After plasma oxidation, 0.2µl of 2% aminopropyltrimethoxysilane (APTMES) (Sigma, 
Canada) was added on ~1 mm
2 
surface of PDMS, in the centre of the flow chamber. After 
10 minutes, a 0.5 µl portion of 0.5mM disuccinimidyl suberate (DSS) (Pierce, USA) 
solution and 5M of Type I fibrinogen from bovine plasma (Sigma) solution was added 
to the APTMES dot in the geometrical centre of the flow chamber. For the experiments 
with collagen immobilization, 8M of collagen type I from rat tail (BD Biosciences) was 
used. The reaction was stopped after 15 minutes by adding Tris buffer pH 8. The 
immobilization chemistry is shown in Figure 1 B.                        
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Aminolysis of succinimidyl group                    
DSS has N-hydroxysulfosuccinimide (NHS) esters at each end and during the 
crosslinking reaction of DSS with primary amines, succinimidyl group is aminolyzed and 
released. The kinetics of the crosslinking reaction was determined by changes in 
absorption by succinimidyl group at 260 nm. The reaction was performed in Tris buffer 
(pH 8) with aminosilane alone, aminosilane and DSS, fibrinogen only, fibrinogen and 
DSS, collage only or collagen and DSS. All measurements were taken using Agilent 8453 
UV-Visible spectrophotometer.                    
               
 
FITC-Fibrinogen labelling and standardization of cross linking time                
Fibrinogen was incubated with fluorescein-isothiocyanate (FITC) at room temperature for 
2 h in the presence of 1 M bicarbonate buffer pH 9.0. The labelled fibrinogen was run 
over G25 column in the dark to remove unbound FITC. Protein concentration was 
determined by bicinchoninic acid (BCA) assay. Aminosilane was added to plasma 
oxidized PDMS surface as described earlier. FITC-fibrinogen was added onto 
aminosilane either with DSS or after 10, 20, 30, 40, 50, 60, 70, 80, 90 and 100 sec of DSS 
addition. After 15 min incubation in dark, excess fibrinogen was washed off with Tris 
buffer and the bound FITC-fibrinogen was detected by Zeiss Axiovert 200 fluorescence 
microscope.                 
 
SDS washing of immobililized fibrinogen                    
Fibrinogen was fluorescently labelled with FITC and immobilized on PDMS by the 
method described above. Fibrinogen-FITC adsorbed on PDMS was used as a control. 
This was followed by addition of 2% SDS and the samples were incubated in dark for 3 
hours. After incubation, the PDMS surface was washed with PBS and images were taken 
using Zeiss Axiovert 200 fluorescence microscope.                 
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Blood collection and washing of platelets                              
Platelets were isolated as described previously (Miersch et al 2007) and were labelled 
with 60 μM BODIPY® FL N-(2-aminoethyl) maleimide (Molecular Probes, Canada). 
After 30 min incubation, platelets were washed twice with HEPES-ACD buffer to remove 
the excess dye and were put back into whole blood.         
 
Light transmission platelet aggregometry            
HEPES ACD was added to BODIPY® FL N-(2-aminoethyl) maleimide labelled and 
unlabelled platelets to get a final concentration of 1 X 10
7
 platelets/mL. 5µM ADP was 
added as an agonist after ~ 40 sec. The platelet samples without ADP were used as 
controls. The kinetics of the aggregation reaction were determined by measuring 
absorbance at 600 nm for 5 min.                                  
 
Perfusion studies in flow chambers                         
The flow cell circuit used for this investigation consists of a custom designed flow 
chamber, PTFE Teflon sterile tubing (0.031” X 0.062”), a medium reservoir, and a 
peristaltic pump (Reglo Digital MS 4/6, model ISM 833, Ismatec).    
              
Statistical analysis                             
Data is expressed as an average of all trials and statistical analysis was done by student’s t 
test.  
Chemical structures in Figure 1 were drawn with ChemDraw 11.0 (Cambridge Software).   
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RESULTS                                  
Flow chamber geometry and immobilization chemistry                    
The conventional flow chambers test platelet adhesion and aggregation by coating 
fibrinogen/collagen on glass slides. In the present study, we plasma-activated an 
otherwise inert matrix PDMS and used a bifunctional, primary amine-directed crosslinker 
DSS, to immobilize platelet-binding proteins on the PDMS surface (Figure 1B).  
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Figure 1 – (A) Geometry of the flow chamber used for perfusion studies. (B) Chemistry 
of immobilizing fibrinogen and collagen on PDMS. Hydroxyl groups were formed on 
inert and hydrophobic PDMS by plasma oxidation. Coating of APTMES on polymer 
surface after plasma oxidation resulted in an amine terminated surface layer. DSS was 
used as a bi-functional crosslinker which reacts both with the amine terminated surface 
layer and with the amine groups of the proteins to be immobilized. 
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Velocity profile                          
 
 
 
 
 
 
Figure 2 – Velocity profile. The graph shows the velocity profile from the inlet to the 
two different points in the centre of the flow device. The velocity of flow is zero in the 
boundary layer and rises monotonically with distance z from the wall, reaching maximum 
at the centre. Z/Zr is the ratio of distance at a given point to the distance to the centre. 
Vy/Vym is the ratio of the velocity at a given point to the velocity at the centre. 
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Crosslinking reaction between fibrinogen/collagen/aminosilane and DSS              
DSS is a homobifunctional crosslinker which has amine reactive NHS esters at both ends. 
It reacts with primary amines in slightly alkaline conditions to yield stable amide bonds. 
This aminolysis reaction releases N-hydroxysuccinimide, which has an absorption 
maximum at 260 nm. The aminolysis reaction between collagen and DSS and fibrinogen 
and DSS is shown in Figure 3 A and B respectively. 
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Figure 3 – Kinetic data for aminolysis of DSS. Aminosilane, fibrinogen and collagen 
were diluted in Tris buffer (pH 8) in different cuvettes. DSS was added after ~ 150 sec 
and kinetics was measured at 260 nm using UV-Vis spectrophotometer (n=3). Samples 
without DSS addition were used as controls.                            
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Variations in time point at which fibrinogen/collagen is added to DSS affects 
immobilization.                                          
Since DSS is a homobifunctional crosslinker, if we add fibrinogen at a later point, all of 
DSS might react with aminosilnae leading to less protein immobilization. To ensure 
complete immobilization of fibrinogen onto PDMS surface, the time point at which 
fibrinogen should be added to DSS has to be determined. FITC labelled fibrinogen was 
added onto the DSS either with DSS or at different time points. The fluorescence was 
maximum when DSS and fibrinogen were added together to aminosilane. There was no 
fluorescence detected when only fibrinogen was added on PDMS surface without any 
immobilization chemistry. 
 
 
 
A 
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Figure 4 – Variations in time point at which fibrinogen/collagen is added to DSS 
affects immobilization. (A) The images show FITC-fibrinogen immobilized on PDMS 
surface where it was added onto aminosilane and DSS at varying time intervals. (B) The 
bar graph shows average fluorescence intensity for FITC-fibrinogen fluorescence, where 
each bar represents the mean ± SD from at least three independent experiments. 
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SDS washing of FITC-fibrinogen                         
Due to the hydrophobic nature of PDMS, it shows high affinity for proteins.
 
In order to 
show that the proteins (fibrinogen/collagen) are covalently linked and not adsorbed, the 
PDMS surface was treated with SDS. Figure 5 illustrates that SDS washes off the protein 
while about 90% of the protein remains on the PDMS-AS-DSS-Fib surface.  
 
 
 
Figure 5 – SDS washing of FITC-fibrinogen. Fibrinogen was labelled with FITC and 
immobilized on PDMS surface. The surface was incubated with 2% SDS for 3 hours and 
was washed with Tris buffer. After 3 hours, the covalently linked protein was still there 
whereas the control showed almost no protein left (n=3). 
 
 
 
 
 
 
 
 
83 
 
Effect of bodipy labelling on platelet aggregation                    
The platelets were fluorescently labelleled with BODIPY FL N-(2-Aminoethyl) 
maleimide for the further experiments. To analyze the effects of the fluorescent label on 
platelet aggregation, light transmission aggregometry was done using UV-Vis 
spectrophotometer. Absorbance at 600 nm was monitored for labelled and unlabelled 
platelets in the presence and absence of ADP. As can be seen from the optical assessment 
of aggregation shown in Fig. 6, bodipy-modification at the levels we employ does not 
interfere with ADP-induced aggregation. 
 
 
Figure 6 – Effect of bodipy labelling on platelet aggregation. The platelets were 
diluted in HEPES ACD and 5 µM ADP was added as an agonist after ~ 40 sec. The 
decrease in absorbance indicates platelet aggregation. The platelets without ADP addition 
were used as control. 
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Validation of the flow chambers          
In order to assess the suitability of the flow chamber and the immobilization chemistry for 
platelet adhesion studies, adhesion to collagen and fibrinogen was tested. Flow chambers 
were placed onto an inverted fluorescence microscope (Zeiss Axiovert 200M. Whole 
blood containing fluorescently labelled platelets was perfused over the flow chambers 
containing either PDMS alone or PDMS-immobilized BSA or fibrinogen or collagen. The 
perfusion rate was 2 ml/min, which generates shear equivalent to that of descending aorta 
(5 dyne/cm
2
). The platelets were either activated by the injection of Ca
2+
 (1 mM) or ADP 
(20 µM) at t=0.  The raw image data, at 40 s intervals, is presented in Figure 7. With the 
controls, PDMS alone or PDMS-immobilized BSA, there were <50 platelets attached 
after 200 s of perfusion (Figure 7).          
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Figure 7 – Comparison of platelet aggregation in normal and type 2 diabetic 
subjects. Whole blood containing fluorescently labelled platelets was passed over PDMS 
alone and PDMS with immobilized BSA, fibrinogen (Fib) or collagen (Coll) using either 
1 mM calcium (Ca
2+
) or 20 µM ADP as activators. The images show time dependent 
increase in platelet adhesion to fibrinogen and collagen, with very little adhesion to the 
controls (PDMS and BSA). The total number of adherent platelets after 200 sec is greater 
in the case of type 2 diabetic (T2D) subjects as compared to normal (N) subjects, 
irrespective of the protein/activator used. All experiments were done at 37
o
C. Images 
were captured in 20 sec intervals by Zeiss Axiovert 200 microscope with achromat 5X 
objective (Carl Zeiss), equipped with a Retiga EX cooled monochrome 12 bit camera (Q 
imaging) and an Xcite series 120 (EXFO,Canada) mercury lamp. Image capture and the 
quantification of the adhered platelets were facilitated by Northern Eclipse software 
(Empix, Canada).  
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Kinetic plots of platelet aggregation          
Images over the immobilized protein (fibrinogen or collagen) field were captured every 
20 s. The platelets were counted in each frame using Northern Eclipse software and the 
kinetic plots were constructed (Figure 8). There is an increased rate of platelet 
aggregation in diabetic subjects as compared to the controls.    
    
  
  
  
Figure 8 – Kinetic plots of platelets adhered to immobilized fibrinogen and collagen 
over time. Blood reconstituted with fluorescently labelled platelets from normal and 
diabetic subjects was perfused through the flow chambers containing immobilized 
fibrinogen and collagen. Graphs (i) and (ii) show platelets adhered to collagen and 
fibrinogen, respectively, over time, when calcium was used as an activator. Graphs (iii) 
and (iv) show increasing number of platelets adhered to collagen and fibrinogen 
respectively, when ADP was used as an activator. The number of platelets adhering over 
time is greater in diabetic subjects (squares) as compared to normal subjects (triangles). 
The platelet binding data is extracted from the entire image data set taken at 20 sec 
intervals. Each point represents the mean ± SD from at least three independent 
experiments. The solid lines represent the best fit line for the first order treatment of the 
binding data: Y=A (1-e
-kt
).   
88 
 
The total number of platelets bound to the protein surfaces are summarized in Table 1. In 
general, the maximum number of platelets bound at saturation (~200 s) was larger for 
platelets from T2D subjects in comparison to those from the normal subjects, under all 
conditions examined.  The largest ratio between T2D to normal of ~1.73 was obtained 
with Ca
2+
-activated platelets on a fibrinogen surface.  The smallest ratio of ~1.31 was 
obtained with ADP-activated platelets on a collagen surface.   
 
 
 
Table 1 – The table shows the total number of normal and type 2 diabetic (T2D) platelets 
± SD attached to fibrinogen (Fib) and collagen (Coll) after 200 sec, with calcium (Ca
2+
) 
and ADP as activators. 
 
 
 
 
 
 
89 
 
 
Table 2 – The first order rate constants were calculated from the kinetic plots of the 
platelet adhesion data. The T2D platelets have higher rate constants as compared to the 
normal (*P<0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
90 
 
Discussion                         
 
The novel aspect of this study is the surface chemistry, which can be utilized for facile 
patterning of immobilized proteins on PDMS surface. The design of the flow device and 
immobilization chemistry introduced here can easily be adapted to microfluidic/lab on 
chip applications for the analysis of hemostasis. The glass coverslip on the bottom of the 
flow chamber can be removed, which allows for cheap and reproducible flow chambers 
for further experiments.         
  The washing of PDMS with SDS could not remove the immobilized fibrinogen. 
This indicates that AS-DSS can bind protein more tightly than physiosorption. Light 
transmission aggregometry illustrated that platelet labeling with Bodipy does not affect 
the aggregation of platelets in response to agonists’.     
 When the whole blood was passed over fibrinogen or collagen coated flow 
devices there was a continuous build up in the adhered platelets over the initial density 
pattern established in the previous time frames indicating that the interaction was 
irreversible. At the end of the binding experiments ~10 mL of buffer was pumped through 
the flow chambers.  The number of adhered platelets did not change, which was a further 
indication of the irreversibility of the interaction with protein matrices covalently attached 
to the PDMS surface. One observation from the kinetic plots of the data was that when 
platelets were activated with Ca
2+
, with either on the collagen or the fibrinogen surface, 
there was a 20 s to 40 s lag prior to the initiation of platelet binding irrespective of the 
platelet source (T2D or normal) (Figure 8 i, ii).  In contrast, this lag was absent in the 
ADP-activated platelets (Figure 8 iii, iv). 
It is well established that in T2D, the platelets have altered in vitro adhesion and 
aggregation patterns and are hypersensitive to agonists as compared to the normal 
platelets (Glassman et al 1993; Dittmar et al 1994; Haouari et al 2008; Vinik et al 2001). 
Therefore, an important step in the validation process was to determine whether our flow 
devices were able to discern functional differences between platelets from normal and 
T2D subjects. To this end, we compared the adhesion kinetics of Ca
2+
 or ADP activated 
platelets from control and T2D subjects onto immobilized collagen and fibrinogen in the 
flow chambers. A qualitative examination of the raw data (Figure 7) revealed that 
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platelets from T2D subjects gave rise to more platelet adhesion irrespective of the 
activator used or the immobilized surface.  These observations were elegantly 
substantiated upon kinetic treatment of the data (Fig 8 i to iv and Tables 1 and 2).   
The rate constants extracted from first order kinetic treatment of the data (Table 2) 
revealed that the binding rate constants for platelets from normal subjects were in general 
independent of the activator used or the protein immobilized since the differences 
between the rates (0.014  0.002 sec-1) were not statistically significant. However, when 
the rate constants of the various activator/protein surface combinations from T2D were 
compared to normal, in all cases the T2D gave rise to 1.12-fold to 1.33-fold larger and 
statistically significant, platelet-binding rate constants (0.018  0.002 sec-1). 
 
Conclusions                                        
In conclusion, here we have introduced a simple and robust method for the construction 
of flow cells made out of PDMS as well as the chemistry for the covalent attachment of 
any platelet-reactive peptides or proteins onto the PDMS surface.  We have also 
demonstrated that the flow cells can readily provide real time data on the kinetics of 
platelet binding and can detect subtle pathological changes in platelet function introduced 
as a result of pathologies such as type 2 diabetes.   
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CHAPTER 4 
Whole blood, flow-chamber studies in real-time indicate a 
biphasic role for thymosin β-4 in platelet adhesion 
 
 
 
 
 
 
 
 
 
 
Published as original research as Kaur et al. 2010 
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Introduction 
 
Thymosin β4 (Tβ4) is a water-soluble, ubiquitous, highly conserved 43-amino acid acidic 
polypeptide (pI 5.1) with a molecular weight of 4.9 kDa (Low et al 1981, 1982; Yu et al 
1994; Goodall et al 1983, 1983). It was originally isolated from the thymus but is present 
in different concentrations in different tissues, cell types and extracellular fluids (blood, 
plasma, saliva, tears). It is found at concentrations of ~5 nM to ~80 nM in plasma to ~500 
μM in platelets (Hannappel et al 1982, 1985, 1987; Huff et al 2001). Tβ4 lacks a 
secretion signal and hence its presence in extracellular fluids could be due to cellular 
damage.           
 The major intracellular function of Tβ4 in mammalian cells is to form a 1:1 
complex with G-actin, preventing its polymerization (Low et al 1981; Hannappel et al 
1985; Safer et al 1991). Apart from its interactions with actin, Tβ4 is capable of 
modulating a wide array of biological functions including tissue (Goldstein et al 2005) 
and wound repair (Sosne et al 2002) as well as anti-inflammatory (Young et al 1999) 
antiapoptotic and neurotrophic (Sun et al 2007) properties. Tβ4 has been also shown to 
play a relevant role in angiogenesis (Smart et al 2009) and neural development (Lin et al 
1990). It also protects the cells against oxidative damage and upregulates anti-oxidative 
enzymes catalase and SOD (Ho et al 2008). The role of Tβ4 in increasing hair growth and 
dermal repair has also been studied, where it promotes stem cell migration and their 
subsequent differentiation into keratinocytes and hair follicles (Philip et al 2004).  
 The ability of Tβ4 to affect these diverse biological functions has been ascribed to 
an array of short, bioactive, peptide sequences within the Tβ4-primary sequence (Sosne et 
al 2010) (Fig. 1). 
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Figure 1 – Location and activity of different peptides derived from Tβ4 (Image 
taken from Sosne et al 2010).  
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The largest concentrations of Tβ4 are found in leukocytes and platelets (Low et al 1981; 
Yu et al 1994; Goodall et al 1983; Hannappel et al 1985, 1987). In resting platelets, it has 
been estimated that ~60% of the actin is prevented from polymerizing by complexing 
with Tβ4 (Fox 1993). Upon platelet activation, Tβ4 is secreted and cross-linked 
enzymatically by factor XIIIa (a transglutaminase) to fibrin in a time- and Ca
2+-
dependent 
manner (Huff et al 2002; Makogoneko et al 2004) thus increasing the local concentration 
of Tβ4 near sites of clots and tissue damage, where it is postulated to contribute to wound 
healing, angiogenesis and inflammatory responses. Platelets carry and release large 
amounts of Tβ4. Yet the role of Tβ4 on platelet thrombus formation has yet to be fully 
investigated. The current study represents a small step towards this goal. Here, we have 
tested the effects of Tβ4 extraneously added to whole blood, on deposition of ADP 
activated platelets onto fibrinogen under conditions of continuous flow and shear. 
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Experimental methods 
 
Subject selection 
Healthy human subjects (n=5), ages 25–40 years were chosen to participate in the study 
only if they showed no overt symptoms of disease and were taking no medication. The 
experimental protocols were approved by the University of Windsor Research Ethics 
Board. 
 
Construction of the flow chamber 
The flow chamber consisted of a Teflon boundary with matching holes (1.75mm) drilled 
through sides a and b (Fig. 2A). The Teflon boundary was first attached onto 1.5 cm 
microscope coverslips by painting a small amount of Sylgard 184 (trade name of 
polydimethylsiloxane- PDMS), (Dow Corning) base plus curing agent (mixed in a 10:1 
ratio). Teflon® tubing (2 cm) was then inserted through the holes and enough Sylgard 
184, (Dow Corning) base plus curing agent was poured to fill the mold. After curing for 6 
h at 60 °C the Teflon tubing was removed by pulling through the holes (sides a or b, Fig. 
2A). The flow chamber was then placed into a plasma cleaner PDC-32G (Harrick Plasma, 
USA) in order to generate silanol groups (Miyaki et al 2007) on the otherwise inert 
PDMS-walls of the flow chamber (Fig. 2B). 
 
Protein immobilization onto plasma activated PDMS surfaces in the flow chambers 
After plasma oxidation, 5 μl of 2% aminopropyltrimethoxysilane (APTMES) (Sigma, 
Canada) was added to the geometric centre of each of the flow channel with the aid of a 
Hamilton syringe. After 10 min, a 0.5-μl portion of 0.5 mM disuccinimidyl suberate 
(DSS) (Pierce, USA) solution was added to the APTMES ring at the centre of the flow 
channels. Within 30 s of DSS addition, either 1 μl of either Type I fibrinogen (5 μM) 
from bovine plasma (Sigma-Aldrich, Canada) or of collagen type I (8 μM) from rat tail 
(BD Biosciences) was introduced into the reaction mixture. The reaction was stopped 
after 15 min by pumping 10 mL of Tris–HCl buffer (0.15 M, pH 8.0) at a rate of 2 ml/min 
through the flow chamber. 
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Blood collection and washing of platelets 
Platelets were isolated as described previously (Miersch et al 2007) and were 
fluorescently labelled by reacting for 30 min, with 60 μM BODIPY® FL N-(2-
aminoethyl) maleimide (Molecular Probes, Canada). The labelled platelets were 
harvested by 2 centrifugation-wash (HEPES-ACD buffer) steps to remove the excess dye 
and were reintroduced into the whole blood sample that they were originally isolated 
from. 
 
Monitoring platelet deposition via flow cells 
A flow cell with the coverslip face-down was placed in the turret of a Zeiss Axiovert 200 
M inverted fluorescence microscope equipped FITC filter cube, and 5×objective. 
Fluorescence images were captured at 20-s intervals with the aid of a CCD camera 
(Hitachi KP-F140F). Two syringe pumps (New Era Pumps, NE-300) were utilized to mix 
the activating  agent (ADP, 400 μM/ Ca2+, 100mM; flow rate 0.05 mL/min) with the 
whole blood containing the fluorescently-labelled platelets (flow rate 0.95 mL/min) at a t-
junction. This yields final Ca
2+
 and ADP concentrations in the flow cell of 5 mM and 20 
μM, respectively. At the start of the experiment only the blood was pumped through the 
channel to adjust the focus and to optimize image capture parameters. At t=0 the 
activating agent pump was started and image capture initiated. A given blood sample was 
pushed separately though each flow channel thus generating 4 sets of binding data per 
sample. The estimated shear on the wall of the flow cells was 150 s
−1
 (5 dyne/cm
2
), which 
represents shear rate in the descending aorta or veins. Image analysis was performed with 
the aid of Northern Exposure 6.0 (Empix, Mississauga, ON) and ImageJ 
(NIH) imaging software packages. 
 
Tβ4 binding assay 
A 96-well plate was filled with 50 μL of PDMS at a ratio of 10:1, base: curing agent. 
Fibrinogen was immobilized on PDMS as described before. Tβ4 was labelled with eosin-
isothiocyanate (EITC) at room temperature for 2 h in the presence of 1 M sodium 
bicarbonate buffer pH 9.0. The labelled Tβ4 was run over a G25 column in the dark to 
remove unbound EITC. Protein concentration was determined by bicinchoninic acid 
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(BCA) assay. Tβ4 was added to the wells at concentrations of 0.1 μM, 0.2 μM, 0.5 μM, 1 
μM, 2 μM and 4 μM. In some wells, unlabelled 4 μM Tβ4 was also added. For control, 
labelled Tβ4 was added to the activated PDMS alone. The plate was incubated under 
gentle agitation for 2 h in the dark. Fluorescence was monitored in the solution before and 
after incubation by Cary Eclipse Fluorescence Spectrophotometer with excitation at 520 
nm and emission at 540 nm. To study the thymosin beta 4 binding to fibrinogen under 
flow, fibrinogen was immobilized in the flow chamber (i.e. the yellow region Fig. 1A) 
and excess eosin-Tβ4 was introduced onto the fibrinogen. The flow chamber was then 
washed with PBS to remove excess eosin-Tβ4. Increasing concentrations of unlabelled 
Tβ4 (10 nM–1 μM) were pumped through the flow cells with a syringe pump (New Era 
Pumps, NE-300) at a rate of 1.0 mL/min and 0.2 mL fractions were collected using a 
fraction collector (Bio-Rad, Model 2110). Fluorescence was monitored in the fractions by 
Cary Eclipse Fluorescence Spectrophotometer with excitation at 520 nm and emission at 
540 nm. 
 
Statistical analysis 
Data is expressed as an average of all trials and statistical analysis was performed by 
Student's t-test the error bars represent s.d. Chemical structures in Fig. 1 were drawn with 
ChemDraw 11.0. 
 
 
 
 
 
 
 
 
 
 
100 
 
 
 
Results 
 
Flow chamber geometry and immobilization chemistry 
 
 
 
 
 
 
Figure 2 – Geometry of the flow chamber and chemistry used for immobilizing 
fibrinogen/collagen in the flow chamber. 
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Validation of the flow chambers 
In these studies, the raw image files collected at 20 s intervals were converted to 8-bit 
gray scale images. We then used the ImageJ plugin, Multi Otsu Threshold introduced by 
Dos Santos et al. (Santos et al 2009) to ensure that we did not count the platelets that 
were transiently associated with the immobilized proteins (appear as streaks in the raw 
images: indicated with arrows in Fig. 3). Otsu multi-thresholding eliminated the streaks as 
well as the out of focus platelets deposited on the edges (see Fig. 2 a, b, c, d, e vs. a', b', c', 
d', e'). The processed-images were subsequently counted by using ImageJ: Step 1 
menu>image>adjust>threshold; and Step 2—Menu>analyze>analyze particles.  
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Figure 3 – Demonstration of the Otsu Multi-Thresholding ImageJ plugin to exclude non-
deposited, transiently associated platelets from being counted in the deposition data. 
Representative raw images obtained at 120 s in flow cells with immobilized BSA, a; 
immobilized collagen with Ca
2+
 as activator, b; immobilized collagen with ADP as 
activator, c; immobilized fibrinogen with Ca
2+
 as activator, d; immobilized fibrinogen 
with ADP as activator, e. The same Images after Otsu Multi Thresholding with 
immobilized BSA, a'; immobilized collagen with Ca
2+
 as activator, b'; immobilized 
collagen with ADP as activator, c'; immobilized fibrinogen with Ca
2+
 as activator, d'; 
immobilized fibrinogen with ADP as activator, e'. Arrows point to non deposited platelets 
appearing as streaks. 
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Platelet deposition on collagen/fibrinogen in the presence of Ca
2+/
ADP   
A representative set of platelet deposition data from blood samples isolated from the same 
subject, exposed to the either Ca
2+
 or ADP as activator with either BSA or fibrinogen or 
collagen immobilized into the flow cell surfaces is presented in Fig. 4 A – F. The platelet 
deposition data for collagen and fibrinogen were well accommodated by a first order 
kinetic process [# of platelets deposited at a given time (t) =Maximum # of platelets 
deposited*(1- e−kobs
*t
)]. The rate constants estimated from first order kinetic treatment of 
the data revealed that the rate of platelet deposition was independent of both the activators 
used (Ca
2+
 or ADP) and the protein immobilized (collagen or fibrinogen) since the 
differences in the rates obtained under the various conditions were not statistically 
significant (Fig. 4G). This same trend was observed with all subjects tested (n=5).  
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Figure 4 – Kinetic plots obtained from particle counts of Otsu Multi Threshold images 
for platelets deposited onto immobilized BSA, A; immobilized collagen with Ca
2+
as 
activator, B; immobilized fibrinogen with Ca
2+
 as activator, C; immobilized 
fibrinogen/collagen without any activator, D; immobilized collagen with ADP as 
activator, E; immobilized fibrinogen with ADP as activator, F; (n=4 from a single 
subject). Composite rate constants: an average rate constant from each subject was 
obtained by performing the deposition experiment under each condition (A to F) in 
quadruplicate. The average value for each condition was then averaged for all the subjects 
(n=4), G. Composite # of deposited platelets: an average # of deposited platelets from 
each subject were determined from the 120 s images by performing the deposition 
experiment under each condition (A to F) in quadruplicate. The average value for each 
condition was then averaged for all the subjects (n=4), H. The solid lines represent the 
best fit line for the first order treatment of the binding data: Y = A (1- e
−kt
). Error bars 
represent s.d. 
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The effect of Tβ4 on platelet deposition under conditions of flow.  
The flow system was then employed to test the effect of Tβ4-dose on the deposition of 
ADP-activated platelets to fibrinogen immobilized flow cells. In these studies, Tβ4, at the 
concentrations indicated (Fig. 5) was incubated for 15 min with the blood/fluorescently 
labelled platelet mixtures before the deposition experiments were carried out. As can be 
seen from the kinetic binding data (Fig. 5A) and a representative data set of the images 
captured at 120 s from the blood samples obtained from the different subjects (S1 to S4, 
Fig. 5B), Tβ4 had a biphasic effect on both the rates of deposition as well as the number 
of platelets deposited. Above a critical concentration of ~0.2 μM Tβ4 the platelet 
deposition is not uniform over the flow cell surface as observed in the control or the 
validation experiments (Fig. 3 and 4). Instead, large thrombi are evident indicative of 
platelet–platelet interactions. These are reflected in the ~4-fold increase in the estimated 
number of platelets deposited (Fig. 5D). The estimated rate constants of platelet 
deposition also increased ~1.5-fold during this process.  
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Figure 5 – The effect of Tβ4-dose on the rate and density of platelet deposition.  
 
(A) Kinetic plots obtained from particle counts of Otsu Multi Thresholded images for 
platelets deposited on immobilized fibrinogen with ADP as activator, as a function of 
Tβ4-dose. The solid lines represent the best fit line for the first order treatment of the 
binding data: Y = A (1- e
−kt
). Error bars represent s.d. (n=4). (B) Representative raw 
images from each subject (S1 to S4) at 120 s as a function of Tβ4-dose. (C) Composite 
rate constants: an average rate constant from each subject was obtained by performing the 
platelet deposition as a function of Tβ4-dose, in quadruplicate. The average value for 
each [Tβ4] was then averaged for all the subjects. Error bars represent s.d. (n=4). (D) 
Composite # of deposited platelets: an average # of platelets deposited from each subject 
was determined from the 120 s images as a function of Tβ4-dose, in quadruplicate. The 
average value for each [Tβ4] was then averaged for all the subjects. Error bars represent 
s.d. (n=4). 
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Tβ4 binding to immobilized fibrinogen 
The decrease in platelet aggregation in the presence of high concentrations of Tβ4 
suggests that Tβ4 might be binding with fibrinogen and hence inhibiting fibrinogen 
mediated platelet aggregation. This led us to propose this hypothesis that Tβ4 might have 
a binding site on fibrinogen. In order to test our fibrinogen binding hypothesis, we 
immobilized fibrinogen onto PDMS on the bottom of 96-well plates using the same 
chemistry as in the flow cells (Fig. 1). We then used a fluorescent Tβ4 derivative, eosin-
Tβ4, to perform equilibrium binding studies. In these experiments increasing amounts of 
eosin-Tβ4 were added to either activated PDMS (Fig. 6A, diamonds) or PDMS-
fibrinogen (Fig. 6A, triangles) or PDMS-fibrinogen containing a constant amount of 
unlabelled Tβ4 (Fig. 6A, circles). There was only significant Tβ4-binding to fibrinogen 
immobilized PDMS and not to PDMS alone or when labelled Tβ4 was added to PDMS-
fibrinogen in the presence of a constant amount of unlabelled Tβ4. These experiments 
indicate that we are observing a specific interaction between fibrinogen and eosin-Tβ4. 
The KD estimated for this interaction was ~126±18 nM (i.e. negative reciprocal of the 
slope of the Scatchard plot of the binding data, Fig. 6B).We also estimated the Tβ4-
fibrinogen interaction under flow. To do this, excess eosin-Tβ4 was introduced onto the 
fibrinogen immobilized in the flow chambers (i.e. the yellow region Fig. 2). The excess 
eosin-Tβ4 was removed by pumping 2 mL of PBS over the flow cells. Next increasing 
amounts of unlabelled Tβ4 was pumped through the flow cells with a syringe pump at a 
rate of 1.0mL/min and 0.2 mL fractions were collected. The total fluorescence (eosin-
Tβ4) summed over fractions 1 and 2 was plotted against unlabelled [Tβ4] (Fig. 6C). The 
data were fitted to the competitive binding equation Eq. (1)  
100% (total fluorescence) - % fluorescence eluted f ([½Tβ4])) =    
     [eosin−Tβ4]          
   KD-eosin−Tβ4 (1 + [Tβ4]/ KD-Tβ4 ) + (eosin−Tβ4)                                                                                                                       
 
where KD− eosin-Tβ4 = the dissociation constant between fibrinogen and eosin-Tβ4; and KD− 
Tβ4 = the dissociation constant between fibrinogen and unlabelled-Tβ4. The KD− Tβ4 
estimated under flow conditions was 66±20 nM. 
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Figure 6 – Binding of eosin-Tβ4 to fibrinogen immobilized on PDMS.     
 
(A) Equilibrium binding of eosin-Tβ4 to fibrinogen. Increasing amounts of eosin-Tβ4 
were added to activated PDMS (diamonds) or PDMS-fibrinogen (triangles) or PDMS-
fibrinogen containing a constant amount, 4 μM, of unlabelled Tβ4 (circles). Bound eosin-
Tβ4 fluorescence = total eosin-Tβ4 fluorescence−free eosin-Tβ4 fluorescence (i.e. 
fluorescence of the supernatant after addition onto PDMS-wells) as a function of eosin-
Tβ4-dose. Error bars represent s.d. (n=5). (B) Scatchard plot of the binding data. 
KD=−1/slope. Error bars represent s.d. (n=5). (C) Binding of eosin-Tβ4 to fibrinogen 
under flow. Increasing concentrations of unlabelled Tβ4 were pumped over the flow cell 
containing immobilized fibrinogen and eosin-Tβ4. The total fluorescence (eosin-Tβ4) 
was plotted against unlabelled [Tβ4]. Error bars represent s.d. (n=3). 
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Discussion                          
 
In the present study, a new perfusion chamber to study platelet adhesion in vitro was 
introduced. To validate the chamber, platelet deposition onto collagen and fibrinogen was 
determined using Ca
2+
 and ADP as activating agents.    
 The average rate constant of platelet accumulation obtained under the various 
conditions (immobilized collagen and fibrinogen with Ca
2+
 and ADP as agonists) was 
0.026±0.0015 s
−1
. This rate constant corresponds to a half-life of 27 s. This indicates that 
the deposition process in the flow system is complete by ~130 s (i.e. 5× half-life). This 
value corresponds well to 2 min to 6 min bleed times (i.e. the time it takes for a small skin 
wound to stop bleeding) in normal humans (Schafer et al 2003). There were also no 
statistically significant differences in the total number of platelets deposited to the flow 
cell surfaces covered with fibrinogen or collagen which is indicative of the reproducibility 
of the immobilization methodology employed here.      
 Platelets have high concentrations of Tβ4 and during blood clotting, Tβ4 
concentration in the serum increases substantially. During blood coagulation, or by ADP 
induced aggregation of platelets, Tβ4 is liberated from platelets and partially cross-linked 
to fibrin by a transglutaminase, factor XIIIa. The covalent cross-linking of Tβ4 to the 
fibrin clot might represent a mechanism to guarantee a high local concentration of the 
peptide at the site of injury, probably supporting subsequent wound healing.   
 When Tβ4 was added to the blood, there was an increase in platelet deposition as 
compared to the controls. However, at high concentrations of Tβ4, the platelet deposition 
diminished. In terms of the half-life of deposition, this corresponds to a decrease from 27 
s to 17 s (i.e. deposition is complete in ~85 s in the presence of Tβ4 as opposed to ~130 s 
in its absence). Interestingly, as the concentration of Tβ4 reaches ~2 μM the deposition 
rates and density return to near normal levels. 
One possible explanation for Tβ4-mediated transient in platelet deposition could 
be that Tβ4 has multiple effects on platelet thrombus formation. At low concentrations 
Tβ4 could promote platelet activation by interacting with platelet receptors (ADP, 
fibrinogen, etc.) converting them to high affinity states. Tβ4 could also bind to fibrinogen 
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in such a manner to prevent its interaction with platelet receptors, thus as Tβ4 
concentrations rise, platelet deposition would be attenuated. 
The binding of Tβ4 to fibrinogen and fibrin in the presence and absence of 
transglutaminase was tested previously (Makogoneko et al 2004). In these studies, 
fibrinogen was attached onto plastic, blocked and the amount of Tβ4-bound was 
estimated by anti-Tβ4-antibodies conjugated to horse radish peroxidase. The 
concentration range of Tβ4 employed was 5 μM to 30 μM. Although these authors did 
observe the largest amounts of Tβ4 incorporation to fibrin in the presence of 
transglutaminase, they did report a small amount of Tβ4-binding to fibrinogen 
(Makogoneko et al 2004).         
 Our present result suggests that there is a high affinity Tβ4-binding domain on 
fibrinogen that was previously undetected possibly owing to differences in the Tβ4-dose 
or the binding assays employed. The fibrinogen binding ability of Tβ4 could explain the 
biphasic response of Tβ4 on platelet deposition under conditions of flow as observed 
here. 
Furthermore, the results obtained in this study suggest a key modulatory role for 
Tβ4 in thrombus formation. At low doses Tβ4 promotes platelet deposition and 
aggregation by as yet unknown mechanism(s). But as platelets are activated and more 
Tβ4 is released from platelets, its serum levels rise and prevent excessive thrombus 
formation by binding to fibrinogen and preventing its interaction with platelets. It is also 
very tantalizing to postulate that platelets hyperactivity in pathologies like type 2 diabetes 
can result from deficiencies in intraplatelet Tβ4. The consequences of this would be that 
more actin would be polymerized in the resting platelet and less Tβ4 would be released 
into the blood during platelet activation to modulate the inhibitory phase by binding to 
fibrinogen thus resulting in platelet hyperactivity. 
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Conclusions                     
 
These results suggest that Tβ4 could potentially increase the affinity of platelet receptors 
for their ligands thus promoting platelet deposition. Tβ4 could also bind to fibrinogen and 
as its concentration increased would prevent platelet–fibrinogen interactions resulting in 
the attenuation of platelet deposition. This work suggests that Tβ4 might have a dual role 
in platelet function. 
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Thymosin beta 4 alleviates endoplasmic reticulum stress in 
retinal pigment epithelial cells 
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Introduction 
Endoplasmic reticulum (ER) stress is caused by the accumulation of unfolded proteins in 
the endoplasmic reticulum lumen. It has been implicated in the pathogenesis of many 
neurodegenerative diseases including Alzheimer’s, Parkinson’s and Huntington’s disease 
(Li et al 2008). All of these diseases are similar to age related macular degeneration 
(AMD) in various pathological features. It has been recently proposed that ER stress 
might have an important role in the pathogenesis of AMD (Salminen et al 2010). It has 
also been shown to play a critical role in the early stages of diabetic retinopathy 
progression (Li et al 2009). ER stress has been triggered by chronic ocular hypertension 
in glaucoma mouse models, which leads to retinal ganglion cell death (Doh et al 2010). 
 The retinal pigment epithelium (RPE) is a monolayer of pigmented simple 
cuboidal cells, which performs many functions essential for vision. The basolateral 
membrane of the RPE faces the Bruch’s membrane and the apical membrane faces the 
photoreceptor outer segments. RPE has many critical functions including transport of 
nutrients (Vitamin A and C) from blood to retina, phagocytosis of the shedded 
photoreceptor membranes, setting up the ion gradients within the interphotoreceptor 
matrix and building up the blood-retina barrier. RPE dysfunction is central to the 
development of AMD.         
 Age related macular degeneration (AMD) is the leading cause of loss of central 
vision in elderly individuals. AMD is characterized by morphological and functional 
abnormalities in RPE cells (Binder et al 2007). The pathogenesis of AMD involves the 
buildup of drusen between Bruch’s membrane and RPE and accumulation of lipofuscin, a 
pigmented aggregate of proteins and lipids, in RPE. Subretinal neovascularization, which 
occurs due to VEGF overexpression in the RPE, is a major development of AMD. 
Recently, it has been shown that ER stress causes increased expression of VEGF (Roybal 
et al 2005).          
 Oxidative stress is a very important factor in the progression and onset of AMD 
and can initiate ER stress in RPE (Beatty et al 2000, He et al 2008). It has been recently 
proposed that ER stress might play an important role in the pathogenesis of AMD (Libby 
et al 2010).         
 Thymosin  4 (Tβ4) is a water-soluble, 43 amino acid polypeptide with a 
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molecular weight of 4.9kDa (Low et al 1981; Yu et al 1994). It is a major G actin 
sequestering protein in mammalian cells. Tβ4 has diverse biological roles including 
angiogenesis, cell migration, tissue protection, and regeneration in skin, eyes and heart. It 
has been previously reported that Tβ4 decreases inflammation and promotes wound 
healing in corneal epithelial cells (Sosne et al 2002). Internalization of Tβ4 has been 
reported in human corneal epithelial cells, HUVEC, bovine corneal endothelial cells and 
human bone marrow-derived mesenchymal stem cells (Grant et al 1999; Ho et al 2007). 
 Herein we hypothesize that ER stress might play an important role in the RPE 
damage during AMD and that Tβ4 can mitigate those effects. In the present study, we 
report that Tβ4 can alleviate ER stress in retinal pigment epithelial cells.   
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Experimental methods 
Cell Culture and treatment                                         
Human retinal pigment epithelium cell line ARPE 19 was obtained from ATCC. Cells 
were grown in 1:1 mixture of Dulbecco’s Modified Eagle’s Medium with Ham’s F-12 
nutrient medium (DMEM F-12; ATCC, USA), 10% fetal bovine serum (FBS, Sigma, 
Canada) and penicillin – streptomycin (Gibco, Canada). The cells were either plated on 
coverslips in 35 mm plates or in 100 mm plates and were incubated at 37°C in 5% CO2 to 
reach ~70% confluence before the experiments. The ARPE 19 cells were incubated with 
either 0.2M or 2M of T4 for 1 hour before inducing ER stress by adding 500 M 
palmitate (Sigma, Canada) in 0.5% BSA (Sigma, Canada). The cells were then incubated 
at 37°C in 5% CO2 for 24 hours. 
Cell viability                     
Cell viability was determined by annexin V and trypan blue staining. For Trypan Blue 
exclusion, cells were seeded in 6 well plates (100,000 cells/well) and grown overnight. 
The cells were treated with Tβ4 and palmitate as described before. After 24 hour 
incubation, the cells were trypsinized and 100μl of the cell suspension was incubated with 
an equal volume of 0.4% Trypan blue solution (Gibco, Canada) for 2 min. Cells were 
counted using a hemocytometer on a light microscope, where live cells excluded Trypan 
Blue staining. For annexin V staining, an annexin V staining kit (BD Biosciences) was 
used. ARPE 19 cells were grown on coverslips in 35mm cell culture plates. The adherent 
cells were incubated with annexin V and propidium iodide (PI) for 15 min. The cells were 
fixed with 3% paraformaldehyde, washed with PBS and viewed under fluorescence 
microscope with a dual filter set for FITC (Annexin V) and rhodamine (PI).  
 
Intracellular ROS production 
The dye H2DCFDA dye is used to detect intracellular ROS. ARPE 19 cells grown on 
coverslips were incubated with H2DCFDA for 30 min at 37°C. The cells were washed 
with PBS 3X and viewed under fluorescence microscope with excitation at 488nm and 
emission at 530nm. 
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Cholesterol detection                         
Cholesterol estimation was done by using filipin (Sigma, Canada). For filipin staining, the 
cells were fixed in 3% paraformaldehyde for 30 min and were then washed 3 times with 
PBS. The fixed cells were incubated with 0.05mg/mL filipin (Sigma, Canada) for 1 hr in 
dark. After incubation, the cells were washed 3X PBS and slides were mounted on slides 
with fluoromount G (Southern Biotech). The slides were viewed under a fluorescent 
microscope using a UV filter with excitation at 340-380 nm and emission at 385-470 nm. 
To detect cholesterol, ARPE 19 cells were also stained with 750 nM PFO-D4-GFP for 30 
min at 37 °C and 5% CO2. The cells were washed three times with HEPES buffer and 
images were taken on an Axiovert fluorescence microscope with 535 nm/550 nm 
excitation/emission. 
Nitric oxide measurement         
ARPE-19 cells were seeded at a density of 2X10
5
 cells in a 10cm plate and were used 
after they reached ~90% confluence.  The cells were pretreated with Tβ4 for one hour and 
then incubated in the presence of palmitate for 24 h. After the termination of the treatment 
times, media was aspirated and fresh media was added. The cells were incubated again 
and after 1 hr, 200 uL of media was withdrawn with a Hamilton gastight syringe and 
directly injected into the purge vessel of a Sievers Nitric Oxide Analyzer (Model 280i) 
which contained acetic acid and sodium iodide. A portion of NO produced by ARPE 19, 
is oxidized by oxygen to form nitrite in the media.  The acidified iodide in the purging 
chamber of the NOA then reduces nitrite to NO. To further determine changes in NO 
production, ARPE 19 cells were incubated with cell culture medium containing 5 M , 
4,5-diaminofluorescein diacetate (DAF-DA , Invitrogen) at 37°C in a 95% air/5% CO2 
incubator for 30 min. Cells were then washed 3X with phosphate buffered saline (PBS) 
and mounted on the stage of an Axiovert 200 inverted fluorescence microscope. DAF-DA 
fluorescence was monitored using excitation and emission wavelengths of 485 and 538 
nm, respectively. 
Immunofluorescence         
ARPE-19 cells were grown on coverslips in 35mm cell culture dishes. For the study of 
nuclear translocation of NF-κB, cells were incubated with 500M palmitate for 24 hours, 
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with or without Tβ4 pretreatment. After incubation, the cells were washed with PBS and 
fixed in ice cold ethanol for 10 min. Rabbit polyclonal antibody against the p65 subunit of 
NFκB (1:200 dilution; Abcam) was used as the primary antibody. Alexa Fluor 488 -
labeled goat anti-rabbit IgG was used as a secondary antibody (1:500 dilution; Santa Cruz 
Biotechnology). Preparations were mounted in Fluoromount G and examined by 
fluorescence microscopy.  
Nuclear and cytoplasmic fractions                    
After treatments, ARPE-19 cells were trypsinized, resuspended and homogenized in 
buffer A (10 mM HEPES pH 7.8, 10 mM KCl, 1.5 mM MgCl2, 0.5% Nonidet P-40, 1 
mM dithiothreitol (DTT) and protease inhibitor cocktail (Sigma)). Nuclei and cytosolic 
fractions were separated by centrifugation at 1000g for 20 minutes. The cytosolic 
fractions (supernatant) were stored at −80°C until further analysis. The nuclear fractions 
(pellets) were resuspended in buffer B (5mM HEPES pH 7.8, 1.5mM MgCl2, 0.2mM 
EDTA, 1mM DTT, 26% glycerol, 300mM NaCl pH 7.8 and protease inhibitor cocktail). 
Nuclei were extracted for 30 min at 4°C. Soluble nuclear fractions were obtained by 
centrifuging at 12,000g for 10 min. Supernatants (nuclear extracts) were stored at −80°C 
until further NFB analysis. Protein concentration was determined by the BCA method. 
Western blots                              
Proteins were extracted from ARPE 19 cells with lysis buffer (10g/L sodium 
deoxycholate, 1% Triton X, 0.01% SDS, 150mM NaCl, 50mM Tris pH 7.5, 0.05 mM 
EDTA, 50mM NaF, 10mM sodium pyrophosphate, 0.5mM sodium peroxyvanadate and 
protease inhibitor cocktail). Protein concentration was determined by the BCA method. 
10 μg of protein samples were resolved in 10% sodium dodecyl sulfate–polyacrylamide 
gel and transferred onto polyvinylidene fluoride (PVDF) membranes. Membranes were 
probed with primary antibodies against anti-rabbit eNOS (1:1000; Abcam), anti-rabbit 
phospho-eNOS (1:1000; Cell Signalling), anti-rabbit p65 subunit of NFκB (1:1000; 
Abcam), anti-rabbit Grp78 (1:1000; Abcam), anti-mouse PDI (1:1000, Abcam), anti-
rabbit Topo II (1:500; Santa Cruz) and anti-mouse actin (1:5000; Abcam). Membranes 
were then incubated with HRP-conjugated anti-rabbit and anti-mouse secondary 
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antibodies (1:2000; Abcam) for 1 h and visualized using enhanced chemiluminescence 
reagent (Pierce, USA).                            
Statistical analysis and images                               
Data is expressed as an average of all trials and statistical analysis was performed by 
Student's t-test. The error bars represent standard deviation. The images were captured 
with a Zeiss Axiovert fluorescence microscope and analyzed using Northern Eclipse. 
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RESULTS 
Cell viability                           
The cells under ER stress for prolonged periods eventually undergo apoptosis. Apoptosis 
is detected by the flipping of phosphatidylserine from the inner leaflet of the plasma 
membrane to the outer leaflet. We determined the viability of the cells using FITC-
Annexin V, which binds to phosphatidylserine and detects apoptosis. PI was used to stain 
the nucleus of viable cells.  As shown in Fig. 1A, no apoptotic signal is observed in 
controls and cells pretreated with 2 µM Tβ4. Very little annexin V binding is seen in cells 
which were under ER stress (no Tβ4 pretreatment) and those pretreated with 0.2µM Tβ4. 
The trypan blue exclusion assay showed that ~92% cells were viable in the controls; 
however the cell viability decreased to ~78% in palmitate treated cells. The ARPE 19 
cells which were pretreated with 0.2 µM and 2 µM Tβ4 had 80% and 82% viable cells 
respectively (Fig. 1B). These results illustrated that after induction of ER stress for 24 
hours, the cells are still viable and healthy and can be used for the subsequent studies. 
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Figure 1 –  Detection of apoptosis and cell viability in ARPE 19 cells treated with 
palmitate with or without Tβ4.                     
ARPE 19 cells were treated with 500 µM palmitate in the presence and absence of Tβ4 
concentrations as indicated. (A) After 24 hours, cells were stained with PI (red) and 
apoptotic cells were detected by Annexin V staining (green). Images were taken of a 
minimum of five different fields in a slide using a 40X oil immersion objective. (B) 
ARPE 19 cells were treated with palmitate and Tβ4 as described before. Live and dead 
cells were determined using the trypan blue exclusion assay. The results are presented as 
percentage of cell viability. Data is shown as mean ± S.D (n=4). 
A 
B 
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Induction of ER stress markers by palmitate                      
Grp78 and PDI are very important markers for ER stress induction. These molecular 
chaperones are upregulated in response to ER stress.  As shown in Figure 2, palmitate 
treatment upregulated expression of Grp78 and PDI proteins which indicates induction of 
ER stress. The Grp78 protein levels are brought down to normal (almost similar to 
controls) when ARPE 19 cells were pretreated with 0.2 µM Tβ4 before inducing ER 
stress.                                                                                        
 
 
 
Figure 2 –  Expression of ER stress markers, Grp78 and PDI, in ARPE 19 cells 
treated with palmitate in the presence or absence of T4.               
ARPE 19 cells were treated with 500 µM palimate with or without Tβ4 for 24 hours. 
Expression of Grp78 and PDI was determined from the cell lysates separated by SDS-
PAGE. The blots were probed with anti-rabbit Grp78 antibody and anti-mouse PDI 
antibodies. Upper and middle panels show PDI and Grp78 expression in response to ER 
stress and Tβ4 pretreatment and the lower panel shows actin, which was used as a loading 
control. The graphs depict the blot densities determined by using Image J (n=3); * P < 
0.05. 
 
Control    ERS      ERS +
0.2µM TB4                            
PDI
Grp78
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Tβ4 attenuates ER stress induced cholesterol production                    
ER stress is known to increase cholesterol levels in cells. Increased cholesterol 
accumulation in RPE has also been associated with the pathogenesis of AMD (Curcio et 
al 2005). The cholesterol determinations in ARPE-19 indicated that there was a ~4.5 fold 
increase in cholesterol in cells under ER stress as compared to controls, however, treating 
the cells with 0.2µM Tβ4 before ER stress induction significantly reduced cholesterol 
levels by ~20%. Pretreatment with 2µM Tβ4 further decreases the cholesterol levels by 
~27% (Figure 3).                                        
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Figure 3 – Effect of Tβ4 pretreatment on cholesterol in retinal pigment epithelial 
cells under ER stress.                     
ARPE 19 cells were treated with palmitate for 24 hours, in the presence or absence of 
Tβ4. (A) The cells fixed with 3% paraformaldehye were stained with filipin (blue) and PI 
(red) and examined by fluorescence microscope. Filipin stains intracellular cholesterol 
and PI stains the nucleus. The pictures were captured using 40X oil immersion objective 
The graph depicts average fluorescence of filipin from four separate experiments (± SD); 
*** P < 0.001. (B) Cholesterol was also estimated by staining with PFO-D4-GFP. After 
treatment, the cells were incubated with PFO-D4-GFP at room temperature. After 30 min 
incubation, the cells were fixed with 3% paraformaldehyde and visualized under 
fluorescence microscope using 40 X oil immersion objective. The graph represents 
average fluorescence of PFO-D4-GFP ± SD (n=4); *** P < 0.001.                 
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Tβ4 pretreatment decreases ER stress induced ROS production                    
Oxidative stress is associated with the onset of ER stress and is one of the most important 
factors associated with the progression of AMD. H2DCFA, a cell permeable dye which 
incorporates into the hydrophobic regions of the cell, was used for this purpose. The 
cellular esterases cleave the acetate moiety leaving impermeant, non-fluorescent, 2′,7′-
dichlorodihydrofluorescein (H2DCF), which is oxidized by reactive oxygen species to 
fluorescent dichlorofluorescein (DCF). To determine whether Tβ4 has the ability to 
reduce reactive oxygen species (ROS) formation after induction of ER stress, the levels of 
ROS were determined. It can be clearly seen in Figure 4 that ER stress increased ROS 
production by ~ 4 fold. Pretreatment with 0.2µM Tβ4 decreased ROS production by ~ 
42%. Higher concentration of Tβ4 (2µM) was able to reduce ROS formation by ~ 57%. 
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Figure 4 – Effect of Tβ4 pretreatment on intracellular ROS production in ER stress 
induced retinal pigment epithelial cells.                 
ARPE 19 cells were incubated with 500 µM ER stressor palmitate, with or without Tβ4 
(0.2μM or 2 µM) for 24 hours. The cells were analyzed for intracellular ROS using 
H2DCFDA. The fluorescence (green) is generated by the oxidized product of H2DCFDA, 
which indicates ROS formation. The graph shows an average of H2DCFDA fluorescence 
and the results are an average of five different set of experiments (n=4); *** P < 0.001.  
Pictures were taken using 63X objective.         
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Tβ4 promotes nitric oxide production and eNOS phosphorylation           
The palmitate treated cells were compared with the controls and Tβ4 pre treated cells with 
respect to nitric oxide production. The nitric oxide was determined in the media, which is 
an indirect method to analyze changes in nitric oxide production by cells. ER stressor 
palmitate decreased nitric oxide production by ~ 55%, but NO production was 
upregulated by ~ 88% in the cells which were treated with Tβ4 before inducing ER stress 
as compared to cells under ER stress (Figure 5A). To further verify the role of Tβ4 in 
nitric oxide production, eNOS expression and phosphorylation was determined. The 
activity of eNOS is increased by its phosphorylation at Ser 1177. As illustrated in Figure 
5C, there is no significant difference in the expression of eNOS in palmitate treated cells 
as compared to the control and Tβ4 pretreated cells. eNOS phosphorylation decreased 
after induction of ER stress by palmitate, whereas pretreatment with 0.2µM Tβ4 
upregulated the phosphorylation of eNOS.                  
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Figure 5 – Effect of Tβ4 on nitric oxide production, eNOS expression and 
phosphorylation in retinal pigment epithelial cells under ER stress.                
The ARPE 19 cells were treated with palmitate in the presence or absence of Tβ4 as 
previously described. (A) After 24 hours, the cells were stained with 5µM DAF-DA for 
30 min. The cells were washed with PBS and viewed under Zeiss Axiovert fluorescence 
microscope using a 20X objective. The graph shows average intensity of DAF-DA 
fluorescence from three independent experiments (± SD); * P < 0.05; ** P < 0.01. (B) 
Total nitrite was measured for retinal pigment epithelial cells treated with palmitate for 24 
hours with or without Tβ4. After treatment, the cell culture media was replaced with fresh 
media and the cells were incubated again for 1 hour. The data shown is representative of 
three different experiments (± SD); * P < 0.05; ** P < 0.01. (C) The expression of eNOS 
and its phosphorylation at Ser 1177 was estimated from western blots using cell lysates of 
control, cells under ER stress and cells treated with 0.2 µM Tβ4 before inducing ER 
stress. The blots were probed with eNOS and Ser1177 phospho eNOS antibodies. Actin 
was used as a loading control.   The graph represents blot densities of eNOS and phospho 
eNOS which were quantified using Image J software.                 
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Tβ4 reduces nuclear localization of NFκB                      
ER stress activates and induces the nuclear translocation of the transcription factor NFκB 
(Pahl et al 1995; Kaneko et al 2003). As demostarted in Figure 6A, the 
immunofluorescence staining of the p65 subunit of NFκB in control cells shows 
cytoplasmic distribution. Incubation with ER stressor palmitate predominantly relocates 
NFκB to the nucleus; however when the ER stressed cells were pretreated with 0.2 µM 
and 2 µM Tβ4, this nuclear translocation was decreased, with large amounts of the p65 
subunit being in the cytoplasm.                      
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Figure 6 – NFκB localization in response to ER stress and T4 pretreatment.                    
(A) ARPE 19 cells were cultured on glass coverslips and treated with 500μM palmitate 
with or without 0.2μM Tβ4 and 2μM Tβ4. The cells were fixed with ethanol and FITC 
conjugated goat anti-rabbit secondary antibody was used to detect the p65 subunit of 
NFκB. Nuclear localization of NFκB is shown by arrows. Images were taken at 40X oil 
immersion objective. (B) Nuclear localization of NFκB was further detected by Western 
blots of nuclear and cytoplasmic fractions. Relative levels of NFκB in nuclear fractions 
were determined. There is a significant increase in nuclear NFκB protein in cells under 
ER stress. Pretreatment with Tβ4 decreases NFκB localization to the nucleus in a 
concentration dependent manner. Actin was used as a control for cytoplasmic fractions 
and Topo II was used as a control for nuclear fractions.   
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Discussion            
RPE dysfunction is one of the key factors involved in the progression of AMD. Retina 
and RPE are under constant oxidative stress due to high metabolic activity, oxygen 
consumption and light absorption. The fluctuations in the redox environment and ROS 
production leads to disturbances in the ER hence causing ER stress (Lai E et al 2007). ER 
stress has been proposed to be an important parameter involved in the pathogenesis of 
AMD. A recent study has shown increased expression of tight junctions in retinal pigment 
epithelial cells in vitro. This has been shown to alter the function of RPE cells which 
might be involved in AMD (Yoshikawa et al 2011). However, not many studies have 
foccussed on the effects of ER stress on RPE cells so far.    
 Tβ4 is a major actin sequestering protein which plays an important role in various 
other physiological processes. It decreases cytochrome c release from the mitochondria 
and also increases the expression of anti-apoptotic gene, bcl-2 (Sosne et al 2005). 
Previous studies have illustrated the role of Tβ4 in decreasing inflammation (Sosne et al 
2002) and preventing apoptosis (Ho et al 2010).     
 In the present study, we illustrated the effects of ER stress on retinal pigment 
epithelial cells and the ability of Tβ4 to alleviate ER stress in RPE. ER stress disrupts 
protein folding in the endoplasmic reticulum leading to accumulation of unfolded 
proteins. An unfolded protein response (UPR) is initiated in order to maintain cell 
homeostasis. UPR upregulates expression of chaperone proteins in order to augment the 
protein folding capacity of the ER. When UPR is not able to alleviate ER stress, it 
initiates an apoptotic signaling pathway, which involves JNK and caspases (Harding et al 
2002; Kaufman et al 2002).            
 In this study, we evaluated the expression of molecular chaperones in retinal 
pigment epithelial cells, in response to ER stress. Grp78 and PDI protein expression were 
upregulated in the cells treated with palmitate, however, Tβ4 decreases the expression of 
these chaperones (Fig. 2). The ability of Tβ4 to decrease Grp78 and PDI levels indicates 
its potential role in protecting the cells against ER stress.     
 The role of oxidative stress in RPE dysfunction and AMD pathogenesis is very 
well known. Previous reports have also linked oxidative stress with ER stress and RPE 
dysfunction. The role of ER stress in RPE neovascularization in AMD has also been 
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implicated (He et al 2008; Libby et al 2010). It has been demonstrated in a previous study 
that there is accumulation of free and esterified cholesterol in the RPE of AMD patients 
(Lakkaraju et al 2007; Curcio et al 2005). The results of our study showed that Tβ4 
pretreatment decreases cholesterol production, which accumulates as a result of ER stress 
(Fig. 3). Oxidative stress, which occurs due to excessive ROS formation, plays a very 
important role in RPE dysfunction. It is illustrated by our results that Tβ4 is able to 
reduce intracellular ROS in RPE and hence protect the cells from oxidative damage.   
 We next determined the effect of Tβ4 on NO formation. Previous reports have 
suggested that there is less production of nitric oxide in the eyes of AMD patients (Bhutto 
et al 2010). In the present study, we demonstrate that Tβ4 is capable of upregulating NO 
production in cells under ER stress, however, when levels of eNOS were determined, 
there was no significant difference in its expression in treated versus untreated cells. 
There was, however a significant difference in the phosphorylation of eNOS at Ser1177, 
in the cells which were pretreated with Tβ4 before induction of ER stress (Fig 5). It has 
been previously reported that Tβ4 can increase eNOS phosphorylation at Ser1177 in 
endothelial progenitor cells (Qiu et al 2009). These results strongly suggest that Tβ4 is 
capable of increasing eNOS phosphorylation and hence NO production in ARPE 19 cells. 
 The induction of ER stress is also associated with the activation of the 
transcription factor NFκB. It is found in the cytoplasm but upon activation it translocates 
to the nucleus, where it further promotes the transcription of various pro-inflammatory 
genes and hence inflammatory signaling pathways. We further show that Tβ4 can also 
decrease nuclear localization of NFκB (Fig. 6). Our observations agree with a previous 
study done in corneal epithelial cells which showed that Tβ4 can minimize nuclear 
localization of NFκB after TNF-α stimulation (Sosne et al 2007).     
                  
Conclusions                            
In summary, the present preliminary study demonstrates the protective effects of Tβ4 in 
retinal pigment epithelial cells under ER stress. More work is required to be done in this 
field to determine the protective effects of Tβ4 in AMD and other retinal diseases. 
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Laminar shear stress is very critical for maintaining proper vascular hemostasis 
functioning and hemostasis. From a clinical standpoint, shear stress is one of the most 
potent endothelial stimulators and it plays an important role in numerous processes 
including vasoregulation, chronic adaptive vessel remodeling
 
(Helmke et al 2002), 
maintaining vascular homeostasis by inhibiting endothelial responses to cytokine 
stimulation (Chiu et al 2002) and in the development of atherosclerosis.  Previous studies 
have shown that areas with low and oscillating shear stress are more prone to 
atherosclerosis (Moore et al 1994; Pedersen et al 1999).     
 Platelet adhesion and thrombus development also depends on the local 
hemodynamic environment to a large extent (Mustard et al 1966). Shear stress plays an 
important role in transporting platelets and mediating their adhesion at the site of injury. 
To understand the mechanisms responsible for platelet function under low and high shear 
rates, many studies have focused on the platelet adhesion to various matrices (fibrinogen, 
collagen) under flow conditions. In all of these studies, coating of glass slides with 
fibrinogen, collagen or vWF has been reported and these flow devices were then used to 
study platelet aggregation mechanisms (Neeves et al 2008; Fuchs et al 2010, Giesen et al 
1999).  This might result in heterogeneous coating and not all the surface might be coated.
 To understand the role of physiological and pathological shear stress in various 
vascular diseases, many flow devices have been engineered (Andrews et al 2010; Man et 
al 2009; Shepherd et al 2009). These flow devices require a large population of 
endothelial cells which needs more chemicals and reagents. Recently, many studies have 
developed microfluidic flow chambers which are very costly. Out of the various flow 
devices available to study effects of shear stress, parallel plate flow chambers are the 
most common. Parallel plate flow chambers are used to mimic flow conditions occurring 
in vivo and study the dynamic response of vascular endothelial cells and platelets to 
controlled levels of fluid shear stress.        
 This thesis describes the development and validation of flow devices to study 
effects of shear stress on endothelial cells and platelet aggregation.  The parallel plate flow 
chamber described in here can be used to study shear mediated effects on endothelial cells 
and platelets. These flow devices are very versatile and economical to make and allow 
real time study of the platelets and endothelial cells exposed to shear stress. In the present 
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study, I report the construction of another flow device for studying platelet function, in 
whole blood, in real time. In these flow chambers, the inert polydimethylsiloxane 
(PDMS) surface was plasma-activated and a homobifunctional cross-linker was used to 
immobilize platelet-binding proteins onto its surface. The current study introduces a new 
facile and robust method for the construction flow chambers which enable the kinetic 
monitoring of platelet adhesion in whole blood.  
Type 2 diabetic patients are at a greater risk of developing vascular diseases like 
atherosclerosis. Increased levels of fibrinogen have been reported in diabetes, which 
might contribute to abnormal clot formation in diabetic patients (Banga et al, 1986). 
Plasmin activator inhibitor 1 (PAI 1) inhibits the formation of plasmin from plasminogen. 
Increased levels of this inhibitor have also been found in the diabetic blood (Juhan-Vague 
et al, 1989). Previous studies have also shown increased levels of vWF activity in 
diabetes (Van Zile J et al 1981). All of these factors contribute to the formation of a 
prothrombotic state in the diabetic patients.       
 The flow chamber developed in this thesis was used to study platelet aggregation 
in diabetic subjects in vitro. The flow chamber was able to discern differences between 
platelets from normal and diabetic subjects. These flow devices provide real time data on 
the kinetics of platelet binding and can detect subtle pathological changes in platelet 
function introduced as a result of pathologies such as type 2 diabetes.  
 Tβ4 is a 43 amino acid peptide found in various tissues and cells including 
platelets. It has been implicated in the sequestering of G actin in mammalian cells. Tβ4 
plays an important role in preventing apoptosis, corneal wound healing, cell survival and 
angiogenesis (Sosne et al 2004; Hinkel et al 2008; Smart et al 2007).    
 The aim of this work was to evaluate the role of Tβ4 in various physiological 
processes. It has been shown previously that Tβ4 is secreted by platelets and is 
crosslinked by factor XIIIa (a transglutaminase) to fibrin in a time- and Ca
2+-
dependent 
manner (Huff et al 2002; Makogoneko et al 2004). This increases the local concentration 
of Tβ4 near sites of clots and tissue damage, where it is postulated to contribute to wound 
healing, angiogenesis and inflammatory responses. Yet the role of Tβ4 on platelet 
thrombus formation has yet to be fully investigated.     
 The current study represents a preliminary effort towards this goal. Here, we have 
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tested the effects of Tβ4 extraneously added to whole blood, on deposition of ADP 
activated platelets onto fibrinogen under conditions of continuous flow and shear. There 
was an increase in platelet deposition when Tβ4 was added to the blood, as compared to 
the controls. However, at high concentrations of Tβ4, a decrease in the platelet deposition 
was observed. The results of the present study suggest that there could be a high affinity 
Tβ4-binding domain on fibrinogen. The fibrinogen binding ability of Tβ4 could explain 
the biphasic response of Tβ4 on platelet deposition under conditions of flow as observed 
here. Furthermore, the results obtained in this study suggest a key modulatory role for 
Tβ4 in thrombus formation. At low doses Tβ4 promotes platelet deposition and 
aggregation by as yet unknown mechanism(s). But as platelets are activated and more 
Tβ4 is released from platelets, its serum levels rises and prevent excessive thrombus 
formation by binding to fibrinogen and preventing its interaction with platelets. 
 Tβ4 has also been shown to decrease inflammation and promote corneal wound 
healing, and various studies have given evidence supporting the role of Tβ4 in cornea 
protection (Ho et al 2008; Sosne et al 2007; Dunn et al 2010). This thesis also 
investigates the effects of Tβ4 on endoplasmic reticulum stress in retinal pigment 
epithelial cells. In this study, we illustrated that Tβ4 is able to reduce ROS production, 
which is an important factor associated with the progression of various ophthalmologic 
diseases including AMD and DR (He et al 2008; Libby et al 2010). Tβ4 also promotes 
NO production and decreases NF-κB nuclear localization in RPE. Our observations agree 
with a previous study done in corneal epithelial cells which showed that Tβ4 can 
minimize nuclear localization of NFκB after TNF-α stimulation (Sosne et al 2007). The 
results reported in this thesis demonstrated that Tβ4 can mitigate the effects of ER stress 
in RPE cells.         
 Overall, the work done in this thesis has done significant contributions in 
understanding the role of Tβ4 in thrombosis. However, more work is needed in this field 
to fully understand the role of Tβ4 in thrombosis and evaluate the mechanisms and 
signalling pathways involved in this process. Very few studies have reported any role of 
ER stress in retinal diseases and this is one of those few studies. This thesis also presents 
preliminary data which demonstrates the protective effects of Tβ4 in retinal pigment 
epithelial cells under ER stress. More extensive study needs to be done in future in this 
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field to get better understanding of the mechanisms involved. In conclusion, the work 
presented in this thesis has made major contributions in development of flow devices to 
study thrombosis and endothelial cell function under flow. This work is also a very 
important step in studying the role of Tβ4 in various physiological processes.  
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APPENDIX  
The results presented in this section of the thesis relate to the studies in Chapter 2 of this 
thesis. 
 
Background                               
Earlier it was assumed that in parallel plate flow chambers, all cells are subjected to the 
same average shear stress. However recently it has been hypothesized that cells are 
subjected to variable shear stress depending on the area in the flow chamber (McCann et 
al 2005). The objective of this study is to develop a flow device to study effects of shear 
stress on endothelial cells and also to develop computational fluid dynamic (CFD) 
template with different shear rates. The templates are designed to match the geometry of a 
custom built in vitro flow cell device and define several regions of shear stress to which 
the cells are exposed during in vitro experiment. Since it has previously been reported 
that shear stress is correlated to NO production in endothelial cells, NO was measured in 
order to validate the proposed flow device and the shear stress template.                     
 
Experimental Methods 
 Cell Culture 
Human dermal microvascular endothelial cells (HDMECs) were purchased from 
ScienCell. The cells were cultured in endothelial cell media (ECM, ScienCell) containing 
10% fetal bovine serum (FBS, ScienCell), pencillin-streptomycin (ScienCell) and 
endothelial cell growth supplement (ECGS, ScienCell) at 37ºC in a 5% CO2 incubator. 
The flow chambers were coated 0.1% fibronectin overnight and endothelial cells were 
grown until 95% confluent. 
In vitro set-up 
The flow cell circuit used for this investigation consists of a custom designed flow cell, 
sterile tubing, a medium reservoir, and a peristaltic pump.  The entire set-up was kept at 
37ºC in a 5% CO2 incubator. The cells were exposed to shear stress for 12 hours. 
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Fluorescence Indicator (DAF-2) 
To determine changes in NO production, endothelial cell monolayers were incubated with 
cell culture medium containing 5 M, 4,5-diaminofluorescein diacetate (DAF-DA , 
Invitrogen) at 37°C in a 95% air/5% CO2 incubator for 30 min. In the presence of oxygen, 
DAF-2 reacts with NO to yield the highly fluorescent triazolofluorescein (DAF-2T).  The 
fluorescence was monitored using excitation and emission wavelengths of 485 and 538 
nm, respectively.   
 
Results                        
Geometry of the flow cell 
The flow cell has the dimensions shown in Figure 2.  The total area on the flow cell 
surface available for cell growth and attachment was 6.85 x 10
-5
m
2
.  The walls of the flow 
cell are made of PDMS (Dow Corning) and the cells are grown on a glass coverslip. 
 
  
Figure 1 –   Geometry of the custom flow cell.                       
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Velocity gradient template 
To simulate the flow in the chamber and estimate the shear stress for the testing program, 
a computational model of the flow channel was developed.   
 
 
                  1mL/min 
 
Figure 2 – Velocity gradient template. 
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Endothelial morphology in response to shear stress                   
The human dermal microvascular endothelial cells were exposed to laminar shear stress 
for 12 hours hours and morphological changes were observed using light microscope. The 
cells become elongated and aligned in the direction of flow; however no such change was 
observed in endothelial cells maintained under static conditions. 
 
  
Figure 3 – Morphology of endothelial cells grown under static and laminar shear 
stress conditions. 
 
 
Effect of shear stress on NOx production                    
In order to validate the flow chamber can be employed for studies in the areas of 
biomedical research; the effect of fluid shear stress on nitric oxide production in 
endothelial cells was examined. NOx formation was upregulated when cells were grown 
under shear as compared to static conditions. The increase in NOx production was more 
in endothelial cells which were exposed to high shear stress for 12 hours, compared with 
those under low shear (Fig. 3). 
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Figure 4 – NOx upregulation in response to shear stress.                      
HDMECs were exposed to shear stress for 12 hours and then stained with 5 μM DAF-
DA. The regions exposed to high shear stress had increased NO production. The graph 
depicts the average fluorescence intensity of DAF-DA (± SD). 
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Discussion                                                                                  
Shear stress plays a critical role in maintaining vascular hemostasis and also in the 
pathogenesis of various diseases, particularly atherosclerosis. Numerous studies have 
focussed on investigating the effects of shear stress on endothelial cells. Parallel plate 
flow chambers are commonly used for this purpose.     
 In this study, we describe the development and validation of a flow chamber for 
shear stress studies. It has previously been shown that the endothelial cells align in the 
direction of the flow and that the alignment would be more pronounced at areas of higher 
shear. Our results also agree with these studies and show similar results.   
 There was an increase in NO production in regions of high shear. These findings 
are in agreement with the previous studies which reported NO upregulation in response to 
shear stress. These results suggest that this chamber can be used to study shear stress 
effects on endothelial cells. This chamber is very simple to make, convenient to use and 
inexpensive.  It can be re used and requires very less number of cells. The shear stress 
template described in here, can be used to define different regions of known shear stress. 
This allows simultaneous exposure to different shear stress levels within one flow cell 
under the exact same experimental conditions.  
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